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 Viruses undergo rapid genetic changes in response to selective forces imposed by 
host immune defenses. All organisms are at risk of virus infections, and the ancient and 
ongoing coevolution between viruses and their hosts have shaped genome evolution for 
both biological partners. One family of viruses, the poxviruses, share a long history with 
humans, and pose a current threat for emerging and re-emerging diseases. Despite the 
extensive history of mammalian poxvirus infections, little is known about the ways in 
which poxviruses adapt to their hosts. In this thesis, I use the model poxvirus, vaccinia 
virus (VACV), in various experimental evolution systems to investigate mechanisms of 
poxvirus evolution. These studies reveal new mechanisms of poxvirus adaptation 
involving recombination-mediated gene amplification events that provide multiple 
benefits to viral fitness. We first identify adaptive copy number variation (CNV) of a 
VACV gene encoding a weak virulence factor that promotes fitness in response to host 
innate immune defenses. Additional gene copies lead to both increased protein expression 
and an increased chance of gaining beneficial point mutations within the expanded gene 
locus. I then show that the presence of CNV can also promote the accumulation of a 
single nucleotide variant in a distant gene. These results establish a direct role for 
recombination in mediating adaptive genetic changes, while simultaneously promoting 
additional adaptations in the form of intragenic and extragenic point mutations. To more 
fully understand the effects of recombination on single nucleotide variant dynamics, I 
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then analyze evolving VACV populations containing a beneficial point mutation within 
expanded gene arrays. New sequencing technologies permit detailed analyses of these 
complex genetic regions, and reveal shared features of genome evolution between VACV 
and a wide array of organisms that highlight the utility of poxviruses as a model system 
to investigate mechanisms of rapid gene conversion. These studies collectively reveal 
new facets of virus adaptation, and add substantially to our understanding of poxvirus 
evolution with potentially broad applications ranging from devising new therapeutic 












Whilst this planet has gone cycling on according to the fixed law 
of gravity, from so simple a beginning endless forms most 
beautiful and most wonderful have been, 
and are being, evolved. 
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Evolutionary conflicts drive genetic change 
Host-pathogen interactions are a major driving force in the evolution of every 
organism. The continuous conflict between pathogen replication and host survival places 
recurrent selective pressure on each side to adapt. These ongoing bouts of selection are 
often described as an arms race in which both host and pathogen undergo repeated 
genetic changes in the battle for evolutionary success. This idea is captured by the classic 
Red Queen hypothesis first put forth by the evolutionary biologist Leigh Van Valen, in 
which he borrows from Lewis Carroll’s book Through the Looking Glass, when the Red 
Queen tells Alice that “it takes all the running you can do, to stay in the same place” (Van 
Valen, 1973). Indeed, despite billions of years of evolution, host-pathogen interactions 
continue to drive adaptation in an endless contest for survival. 
At the molecular level, adaptations often occur at protein-protein interfaces where 
host and pathogen-encoded factors directly interact. These interactions arise because 
pathogens utilize a range of host factors to promote replication, and hosts deploy 
numerous factors to detect and defend against infection. Thus, different types of 
interactions dictate the kind of adaptation observed at the protein level. From the host 
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perspective, proteins hijacked or antagonized by pathogens are often evolving 
defensively to alter surfaces such that the interacting pathogen protein can no longer bind 
(Daugherty and Malik, 2012). Alternatively, host defense proteins targeting specific 
pathogen functions evolve offensively to maintain the interaction (Daugherty and Malik, 
2012). Changes in host proteins place selective pressure on the pathogen to evolve 
compensating mutations to reestablish or abolish the interaction. These back-and-forth 
adaptations on specific protein surfaces create hot spots of rapid evolution for both hosts 
and pathogens, which can be detected in genomic sequences. 
Within genomes, the random occurrence of point mutations generates variation 
upon which selection can act. In protein-coding genes, synonymous mutations, or 
nucleotide changes that do not alter the amino acid sequence, are often neutral and have a 
stochastic chance of becoming fixed in a population over time. Nonsynonymous 
mutations, which do change the resulting amino acid, can have varying fitness effects 
with diverse outcomes in response to selection. Deleterious mutations affecting protein 
function are selected against, implying constraint. Over evolutionary time, constraint is 
detected in the form of amino acid conservation, also known as purifying selection 
(Daugherty and Malik, 2012). Highly variable residues instead suggest that 
nonsynonymous mutations are being selected for, and these are examples of positive or 
diversifying selection (Holmes, 2004; Hurst, 2002). Comparing the rate of 
nonsynonymous to synonymous point mutations (dN/dS) within a gene across large 
phylogenetic distances provides a means of detecting instances of purifying (dN/dS < 1) 
or positive (dN/dS >1) selection (Hurst, 2002; Pond et al., 2005; Yang, 2007). Genes 
encoding proteins involved in molecular arms races are often under positive selection, 
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due to recurrent selective pressure acting to fix nonsynonymous changes that alter 
binding interfaces (Daugherty and Malik, 2012). Evolutionary analyses aid the 
identification of Red Queen conflicts between pathogen and host proteins (Daugherty and 
Malik, 2012; Holmes, 2004), and studying these arms races can help to understand how 
both hosts and pathogens evolve. 
 
Evolution of host genomes in response to pathogens 
Complex organisms, such as mammals, must compete with pathogens which 
possess higher mutation rates, larger population sizes, and shorter reproductive times. 
The odds seem stacked against the host, yet mammalian genomes have the advantage of 
size, and are capable of encoding a great variety of genes dedicated to defending against 
pathogens. Complexity and diversification of immune genes in response to a long history 
of infections has shaped mammalian immune responses to greatly constrain the 
evolutionary success of pathogens (Daugherty and Malik, 2012; Meyerson and Sawyer, 
2011; tenOever, 2016). The large genome size of mammals is also in part a direct 
consequence of infections, through the incorporation of retroviruses into the genome of 
their host. Endogenized retroviruses make up a large portion of many animal genomes 
with a significant impact on various processes, emphasizing the importance of the ancient 
relationship between viruses and their hosts (Bannert and Kurth, 2006; Katzourakis et al., 
2005). Analyses of host genomes also provide evidence of various adaptive outcomes in 
response to infection. While many adaptations reveal a history of selection for changes 
beneficial to the host, there are cases where adaptation to avoid infection may not 
increase host fitness overall. Antagonistic pleiotropy can arise when evolutionary 
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tradeoffs occur such that mutations beneficial in one environment are detrimental in 
another. One of the most well-known examples is the maintenance of hemoglobin alleles 
in humans that provide resistance to malaria, at the expense of sickle cell anemia in 
homozygous individuals (Ashley-Koch et al., 2000). These different outcomes 
demonstrate how varied adaptive strategies play out over time, resulting in fixed changes 
in host genomes that belie the volatile history of interactions with various pathogenic 
threats. Evolutionary analyses can uncover these adaptations, which aid in understanding 
the effects driving changes in various genomes and animal populations. 
Identification and analysis of molecular arms races demonstrate the power of 
using an evolutionary perspective to reveal how genetic changes can rapidly influence 
host adaptation. Phylogenetic analyses across different primate species have shown that 
genes under positive selection are enriched for those encoding immunity factors (George 
et al., 2011; Nielsen et al., 2005). These include a number of well-characterized pattern 
recognition receptors and restriction factors, which are host-encoded proteins that detect 
and inhibit infections, respectively. The observed signatures of diversifying selection are 
likely a result of repeated antagonism by pathogens such as viruses (Daugherty and 
Malik, 2012; Duggal and Emerman, 2012) and bacteria (Wlasiuk and Nachman, 2010) 
during Red Queen conflicts. Molecular arms races can also involve host proteins required 
for essential cellular functions, highlighting the complex interactions between pathogens 
and their hosts. For example, the requirement for transition metals has resulted in the 
regulation and sequestration of metals by hosts, termed “nutritional immunity”, and 
scavenging of metals by pathogenic bacteria (Hood and Skaar, 2012) and fungi (Potrykus 
et al., 2014). Transition metals are required in many essential biological processes, and 
		
5	
thus host transport proteins may be subject to evolutionary constraint. However, recently, 
it was shown that the iron transport protein transferrin in primates is involved in an 
ongoing conflict with the bacterial iron scavenging protein TbpA (Barber and Elde, 
2014). In this study, signatures of positive selection in transferrin helped identify critical 
residues at the TbpA binding interface, and validated functional consequences of genetic 
variation in transferrin for resistance to bacterial pathogens. This type of detailed 
evolutionary analysis demonstrates the ability to uncover new aspects of adaptation in 
response to pathogens, and has been applied to a number of host-pathogen interactions. 
The collective study of molecular arms races identified using markers of positive 
selection reveals patterns that are beginning to guide our understanding of how these 
interactions shape evolutionary change (Daugherty and Malik, 2012). Virus-host 
interactions in mammals provide a particularly useful system to understand adaptive 
strategies relevant to human health and evolution. For example, specific residues under 
positive selection can alter interactions between host and pathogen proteins, which was 
first demonstrated by examining the interaction between the antiviral factor tripartite 
motif-containing protein 5 alpha (TRIM5α) and human immunodeficiency virus 1 (HIV-
1) (Sawyer et al., 2005). In this study, the authors showed that swapping just five amino 
acids under positive selection from the restrictive rhesus monkey protein into human 
TRIM5α conferred resistance to HIV-1. It was later shown that a single amino acid could 
largely determine the specificity of the interaction between TRIM5α and the HIV-1 
capsid (Stremlau et al., 2005; Yap et al., 2005), and a similar observation was made for 
the interaction between the restriction factor SAM and HD domain containing 
deoxynucleoside triphosphate triphosphohydrolase 1 (SAMHD1) and the lentivirus 
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protein Vpx (Laguette et al., 2012; Lim et al., 2012). Thus, even single amino acid 
changes can have a dramatic impact on the ability of host restriction factors to bind viral 
products, which in turn can determine whether a host is susceptible to infection. Taking 
an evolutionary approach to study this type of interaction can therefore elucidate critical 
residues involved in immune defenses, providing new information to guide therapeutic 
approaches. Additionally, these analyses uncover the various ways in which host 
genomes have been shaped by infections, with the potential to inform our understanding 
of future infection dynamics. 
 
Evolution of pathogens in response to host defenses 
With the continuous threat of existing and emerging infections, it is essential to 
understand how pathogens evolve in response to immune responses and medical 
treatments. Pathogens are capable of extremely rapid change, dictated largely by their 
interactions with a host. By definition, a pathogen must interact with a host, and 
consequently face intense selective pressure from host defenses. Pathogens utilize a 
variety of adaptive strategies in response, including high point mutation rates relative to 
their hosts for the rapid sampling of variants (Drake et al., 1998; Lynch, 2010; 
Sniegowski et al., 2000). Particularly for bacteria, horizontal gene transfer, or the 
exchange of genetic material, is another critical source of adaptation (reviewed in de la 
Casa-Esperón, 2012; Koonin, 2016). Acquisition of an entire gene can deliver immediate 
innovation, and has also been observed in some large DNA viruses (Filée et al., 2008; 
Hughes and Friedman, 2005). Amplification of existing genes in bacteria similarly 
generates extensive genetic variation on which evolution can act. Gene amplification 
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events in response to host pressures can promote enhanced survival in the host 
environment, and have also been shown to increase virulence (Andersson and Hughes, 
2009). These few examples highlight the complex nature of pathogen evolution, and 
indeed a multitude of adaptive mechanisms are employed by the diverse array of 
pathogens. However, general principles and strategies can still be discovered when 
studying individual pathogens as they evolve. 
At the molecular level, the evolution of pathogen proteins involved in Red Queen 
conflicts share many similarities with mechanisms of host adaptation. As in the examples 
listed above for host genes, positive selection can be used to identify pathogen genes 
undergoing rapid evolution during ongoing arms race scenarios (reviewed in Aguileta et 
al., 2009). While analyses of dN/dS ratios can be more complicated in pathogen 
genomes, due to confounding effects like bottlenecks, horizontal gene transfer, and 
recombination, they can still aid in identification of host-pathogen arms races. Pathogen-
encoded proteins that directly interact with host proteins showing signatures of positive 
selection are often also rapidly evolving. For example, the bacterial receptor TbpA that 
binds host transferrin shows evidence of recurrent selection at the interaction interface 
(Barber and Elde, 2014). Similarly, a common finding among viruses is the concentration 
of positively selected residues on surface-exposed proteins, suggesting direct interaction 
with host factors. In some instances, these proteins are likely under selection from 
recognition by host adaptive immune system components, as in the case of dengue virus 
surface proteins (Bennett et al., 2006), influenza virus hemagglutinin and neuraminidase 
(Li et al., 2011), and the SARS coronavirus spike protein (Zhang et al., 2006). Selection 
to bind host receptors can also elicit changes to surface proteins, as observed in the 
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glycoprotein of Ebolavirus (de La Vega et al., 2015). Small differences affecting host 
receptor binding can even lead to changes in host range, as in the well-studied emergence 
of canine parvovirus in dogs through alterations to the major capsid protein (Hueffer and 
Parrish, 2003; Shackelton et al., 2005). Thus, analyses of positive selection in pathogen 
genomes can identify evolutionary hot spots, and reveal important innovations that 
provide insight into various aspects of pathogen evolution, including pathogenesis, 
virulence, and tropism. 
While comparative analyses of existing organisms provide a means of identifying 
ongoing host-pathogen arms races, there are still many open questions about the 
dynamics of evolutionary change. The field of experimental evolution allows for more 
direct observations of evolution in action and testing hypotheses about the processes 
involved. Microorganisms are particularly amenable to experimental evolution due to 
large population sizes, short generation times, and asexual reproduction. This permits 
observation of genotypic and phenotypic changes in microbial populations under 
controlled conditions over many generations. Studies using microbes, namely viruses, 
bacteria, and yeast, have observed how fitness changes over time, and how the rate of 
adaptation is affected by parameters such as population size, population structure, and 
environment (reviewed in Barrick and Lenski, 2013; Elena and Lenski, 2003). The 
advent of new sequencing technologies has also enhanced the ability to track genetic 
changes, leading to new insights such as the role of epistasis in genome evolution 
(reviewed in Jerison and Desai, 2015). These findings support broad evolutionary 
mechanisms shared among different organisms, and highlight the utility of microbial 
experiments to understand general evolutionary principles. 
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While the discovery of common adaptive mechanisms reinforces evolutionary 
theory, it is also important to consider the dynamics of adaptation for specific types of 
microbes. The huge impact of pathogenic microbes on human and animal health 
necessitates a better understanding of the specific mechanisms driving pathogen 
evolution. Viruses provide a particularly useful system to study evolutionary processes, 
as they are associated with every life form, and thus have influenced host-pathogen 
evolution since the beginning of cellular life (Koonin and Dolja, 2013). Experimental 
evolution studies using phages have been used to advance our understanding of viral-host 
adaptation, with applications to general virus biology and evolution (Hall et al., 2013). 
This framework exploring viral evolutionary processes is also being applied to medically 
relevant viruses, including the impact of codon usage in poliovirus (Lauring et al., 2012), 
and different selection outcomes for arboviruses in mosquito or vertebrate hosts with 
West Nile virus (Deardorff et al., 2011; Jerzak et al., 2007; 2008), chikungunya virus 
(Coffey and Vignuzzi, 2011), and dengue virus (Vasilakis et al., 2009). These studies can 
have major implications towards our understanding of viral success, demonstrated by the 
selection and emergence of epidemic chikungunya virus strains in an experimental 
system (Stapleford et al., 2014). Thus, this type of experimentation can reveal new 
mechanisms of viral evolution, which in turn could help inform strategies to combat viral 
infections. Combining evolutionary perspectives from both the virus and host viewpoints 
exposes mechanisms of adaptation and counter-adaptation, affording a deeper 
understanding of the forces shaping infection dynamics. Information regarding the 
molecular determinants of resistance and susceptibility could someday even enable 




Introduction to poxviruses 
 The virus family Poxviridae is comprised of large, complex viruses containing 
linear double-stranded DNA (dsDNA) genomes. These viruses replicate solely in the 
cytoplasm of host cells, and infect a wide range of arthropod (Entomopoxviruses) and 
vertebrate (Chordopoxviruses) hosts (Moss, 2013a). Among the poxviruses are medically 
important species capable of infecting humans, most notably variola virus, the causative 
agent of smallpox. Indeed, humans have a long history with poxvirus infections 
(Behbehani, 1983), and some estimates even suggest that smallpox has killed more 
humans in recorded history than all other infections combined (McFadden, 2005). While 
the successful eradication of smallpox through worldwide vaccination programs has 
eliminated this threat, other poxviruses capable of zoonotic infections, including 
monkeypox and cowpox, pose a risk to human health through outbreaks or potential acts 
of bioterrorism (Essbauer et al., 2010). Emerging and re-emerging viral diseases 
represent an area of particular concern, due to a lack of treatments and the lag time in 
creating vaccines in response to epidemics (McCloskey et al., 2014; Morens et al., 2004). 
It is therefore critical to understand zoonotic threats, and to do this, more information is 
needed regarding how different types of viruses function and evolve. 
 Most studies of poxviruses concentrate on the Orthopoxvirus genus of the 
Chordopoxviruses, since this clade includes variola virus and others with zoonotic 
potential. Importantly, the Orthopoxvirus genus also includes vaccinia virus (VACV), 
which was the vaccine strain used to eradicate smallpox. VACV is also the model 
poxvirus, and most of the current knowledge regarding poxvirus biology and immune 
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modulation stems from studying vaccinia. The VACV genome is representative of 
poxvirus complexity, in terms of both structure and composition. About 200 genes are 
encoded within the ~200kbp VACV genome (Goebel et al., 1990), approximately half of 
which are shared among Chordopoxviruses, and 49 of which are shared among all 
poxviruses (Upton et al., 2003). These conserved poxvirus genes are concentrated in the 
center of the genome, and encode proteins with essential functions in processes such as 
entry, replication, transcription, and virion assembly (Gubser et al., 2004; Upton et al., 
2003). Genes on either end of the genome are more variable between poxvirus species, 
and encode many virulence genes that modulate host immune responses (Gubser et al., 
2004; Moss and Shisler, 2001; Seet et al., 2003). Analyses of poxvirus phylogeny and 
evolution (reviewed in Lefkowitz et al., 2006) show a greater similarity between poxvirus 
proteins and eukaryotic rather than prokaryotic proteins, supporting recent and ancient 
gene acquisition from hosts via horizontal gene transfer (Bratke and McLysaght, 2008; 
Hughes and Friedman, 2005; McLysaght et al., 2003; Odom et al., 2009). Poxvirus 
genome size and complexity both contribute to the evolutionary success of these viruses 
in a wide range of hosts. 
The poxvirus replication cycle has been best studied in VACV, and entails 
binding, entry, transcription of viral genes, replication of the DNA genome, and assembly 
and morphogenesis of new viral particles (Figure 1.1). Unlike many other viruses, 
poxvirus replication takes place solely within the host cell cytoplasm, and new virions are 
generated after about 8 hours (Moss, 2013a). Another unique feature of poxviruses is the 
existence of two main forms of infectious particles, the intracellular mature virion (IMV) 
and the extracellular enveloped virion (EEV), thought to facilitate infection between 
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hosts or within a host, respectively (Moss, 2013a).  Both the IMV and EEV forms can 
enter cells at the plasma membrane or following marcopinocytosis, using at least 15 viral 
proteins for attachment and membrane fusion (reviewed in Moss, 2012; 2016; Schmidt et 
al., 2012). After virion fusion, early transcription takes place within the viral core, in 
which the viral RNA polymerase and encapsidated viral transcription factors transcribe 
the viral set of early mRNAs (Broyles, 2003; Moss, 2013a). Next, the viral DNA is 
released into the cytoplasm following core dissolution, where it functions as a template 
for genome replication (Moss 2013b). DNA replication factors are among those 
transcribed as early genes, including the viral DNA polymerase, a helicase-primase, a 
processivity factor, a DNA ligase, and a single-stranded DNA binding protein (reviewed 
in Moss, 2013b). Post-replicative transcription continues in a temporal manner, in which 
intermediate gene transcription requires early products, and late gene transcription 
requires intermediate products (Broyles, 2003; Yang et al., 2013). Intermediate and late 
gene transcripts encode structural proteins and other factors required for virion assembly 
and morphogenesis, as well as early transcription factors that are packaged in the virion 
(Broyles, 2003). Virion morphogenesis takes place in virus factories within the host cell 
cytoplasm, utilizing host membranes to construct the different virion forms. The IMV 
form is made first, surrounded by a single membrane, and remains intracellular until cell 
lysis (Roberts and Smith, 2008; Smith and Law, 2004). Some IMVs are further enveloped 
by host membrane and transported to the cell surface, where they are released as EEVs 
(Roberts and Smith, 2008; Smith and Law, 2004). Many of these general features of 
VACV replication are highly conserved among poxviruses (Moss, 2013a), demonstrating 
the utility of VACV as a model for studying poxvirus biology. 
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Orthopoxvirus host range and immune modulation 
The host range of different Orthopoxviruses varies widely, from single host 
specificity (variola virus) to a large variety of hosts (cowpox virus), likely due to the 
diversity in encoded virulence factors (Haller et al., 2014). At the cellular level, tropism 
is determined downstream of binding and entry, as no specific host receptors have been 
identified (McFadden, 2005). The specific interactions between the host cellular immune 
response and host range factors encoded by the virus thus determine whether a productive 
infection takes place (Bratke et al., 2013; Haller et al., 2014; Werden et al., 2008). Many 
of the poxvirus virulence factors affecting host immune responses were first identified 
through shared homology with cellular gene products (Bugert and Darai, 2000). These 
represent examples of protein mimicry, in which the viral gene likely arose through 
acquisition by horizontal gene transfer from a host followed by divergent evolution (Elde 
and Malik, 2009). Protein mimics and other immune modulatory proteins comprise the 
set of poxvirus virulence factors capable of influencing various host defense pathways to 
mount a successful infection. 
Poxvirus virulence factors induce changes to the host immune system through 
three main mechanisms: modulating extracellular communication signals to promote a 
protected microenvironment, altering intracellular signaling pathways, and masking signs 
of infection to reduce activation of host defense pathways (reviewed in Moss and Shisler, 
2001; Seet et al., 2003). In the extracellular environment, poxviruses target key immune 
signaling molecules, including interferons, tumor necrosis factor, interleukins, cytokines, 
chemokines, and complement (Seet et al., 2003). These effects are often elicited by 
viroceptors, altered and sometimes secreted versions of cellular receptors that compete 
		
14	
for ligands, and virokines, secreted viral proteins that mimic host cytokines or their 
inhibitors (Johnston and McFadden, 2004; Moss and Shisler, 2001; Seet et al., 2003). The 
combined action of these viral effectors is to downregulate the early inflammatory 
response, creating a local environment that favors establishment of infection. Within 
infected cells, poxviruses also modulate a number of pathways to promote a favorable 
cellular environment. This includes disruption of apoptotic, interferon receptor, and IL-
1b receptor signaling pathways, to downregulate cell-intrinsic innate immune responses 
(Johnston and McFadden, 2003; Moss and Shisler, 2001; Seet et al., 2003). Poxviruses 
also encode virulence factors that thwart cell detection pathways, blocking immune 
responses at the earliest stages of infection. Strategies include targeting host pattern 
recognition receptors (PRRs) that detect features common among pathogens, as well as 
masking these pathogen-associated molecular patterns to prevent PRR activation 
(Johnston and McFadden, 2003; Moss and Shisler, 2001; Seet et al., 2003). Collectively, 
the numerous immune evasion techniques employed by poxviruses emphasize their 
complex interactions with a host, and highlight the importance for these viruses to 
overcome early immune responses. 
Specific interfaces between poxviruses and cellular immune defenses illustrate the 
dynamic nature of host-pathogen interactions. The interface between the host PRR 
protein kinase R (PKR) and VACV host range factors is an illustrative example of the 
complex interactions that can determine the outcome of infection (Figure 1.2). PKR is a 
broadly antiviral cytoplasmic host nucleic acid sensor, activated by double-stranded RNA 
(dsRNA) produced during many viral infections (Weber et al., 2006). Upon activation, 
PKR phosphorylates its substrate, eukaryotic translation initiation factor 2a (eIF2a), 
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leading to a global block in protein translation (Meurs et al., 1990). PKR activation also 
induces apoptosis (Gil and Esteban, 2000), thus impeding viral replication on multiple 
fronts. This places selection on viruses to inhibit PKR activation, and indeed a wide 
variety of viruses encode proteins that antagonize PKR (Langland et al., 2006). In turn, 
repeated and diverse viral antagonism has resulted in the rapid evolution of PKR in 
mammals during this complex molecular arms race (Elde et al., 2009; Rothenburg et al., 
2009). The interaction in poxviruses is no less complex, with two separate PKR inhibitors 
encoded by many Orthopoxviruses (Bratke et al., 2013). In VACV, the products of the 
genes E3L and K3L both inhibit PKR (Beattie et al., 1991; Carroll et al., 1993; Chang et 
al., 1992), although through different mechanisms (Davies et al., 1993). E3L blocks PKR 
activation by binding dsRNA (Watson et al., 1991) and thus also inhibits other dsRNA 
binding proteins such as oligoadenylate synthetase 1 (OAS-1) (Davies et al., 1993) and 
adenosine deaminase acting on RNA 1 (ADAR1) (Liu et al., 2001). K3L is a protein 
mimic of eIF2a, and therefore specifically inhibits PKR as a pseudosubstrate (Dar and 
Sicheri, 2002). Both E3L and K3L are host range factors required for optimal fitness in 
different host species, which likely contributes to the retention of two independent PKR 
inhibitors in VACV (Langland and Jacobs, 2002). Examination of host-pathogen 
interactions in this single example highlights how the interplay between viral and host 
fitness can result in complicated relationships arising from different evolutionary 
strategies. These relationships can then be leveraged to test how a virus or host will adapt 






 The ancient and ongoing conflicts between pathogens and their hosts have shaped 
genome evolution, leaving behind genetic imprints that can be used to trace adaptive 
strategies and outcomes for diverse organisms. Identification and analyses of genetic 
conflicts driven by host-pathogen interactions provide a wealth of information to 
understand the ways in which our own evolutionary history has been shaped by 
infections, as well as the various tactics pathogens employ to persist and propagate. This 
knowledge can be used to inform efforts to fight current and future pathogenic threats. 
Emerging and re-emerging diseases with pandemic potential are a global issue, 
particularly in the current age of worldwide travel and environmental changes increasing 
the chance of zoonoses (Morens et al., 2004). Lessons from history aid preparedness, but 
it is impossible to predict what form the next epidemic will take. Therefore, it is critical 
to study a diverse array of infectious agents, particularly those with pandemic potential, 
to be equipped with an understanding of how pathogens function and evolve. 
Viruses are an enormously diverse group of obligate intracellular pathogens that 
have coevolved with all forms of life. The remarkable diversity in size, shape, genome 
complexity, and gene content among viruses exemplifies the varied and complex nature 
of virus-host interactions. Numerous viruses pose a serious threat to human and animal 
health, but to group viral diseases together greatly oversimplifies the incredible variety of 
virus types and adaptive strategies. Poxviruses are a virus family with a long history of 
infection in animals. Estimates of smallpox origins make it one of the oldest human 
pathogens, and it was also the first pathogen to be eradicated through the development 
and implementation of vaccination (Behbehani, 1983). Despite the history and extensive 
		
17	
study of the related vaccinia virus, little is known about how poxviruses evolve. The 
potential exists for poxviruses to cause epidemics through zoonosis or bioterrorism 
(Essbauer et al., 2010), and thus a deeper understanding of the ways in which these 
viruses adapt is needed. VACV provides a tractable model system in which to study 
poxvirus evolution, as studies with VACV have uncovered most of what is currently 
known about poxvirus biology. The work presented in this dissertation utilizes an 
experimental evolution system to study VACV biology, which reveals new mechanisms 
of poxvirus adaptation. Application of an evolutionary framework to study virus-host 
interactions exposes the intricate, complex, and sometimes unexpected nature of selection 
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Figure 1.1. Poxvirus replication cycle. Poxvirus replication takes place in the cytoplasm 
of host cells. Infection initiates with binding and entry of infectious IMV or EEV virions 
(1). Early transcription occurs within the capsid (2), followed by uncoating of the viral 
genome (3) and DNA replication (4). Post-replicative transcription of intermediate and 
late genes follows in a temporal manner (5), producing structural proteins required for 
virion assembly (6) and maturation (7) to form infectious IMV particles. These virions 
can be further processed and transported to the cell membrane, where they are released as 
























Figure 1.2. Vaccinia virus inhibits the PKR pathway. Double-stranded RNA produced 
during the viral lifecycle is detected by the host nucleic acid sensor PKR. Upon binding 
dsRNA, PKR becomes activated and phosphorylates its substrate, eIF2a. Phosphorylated 
eIF2a leads to a global block in protein translation. VACV encodes two inhibitors of the 
PKR pathway, E3L and K3L. E3L binds dsRNA and prevents PKR activation, while K3L 
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SUMMARY
In contrast to RNA viruses, double-stranded DNA
viruses have low mutation rates yet must still adapt
rapidly in response to changing host defenses. To
determine mechanisms of adaptation, we subjected
the model poxvirus vaccinia to serial propagation in
human cells, where its antihost factor K3L is malad-
apted against the antiviral protein kinase R (PKR).
Viruses rapidly acquired higher fitness via recurrent
K3L gene amplifications, incurring up to 7%–10% in-
creases in genome size. These transient gene expan-
sions were necessary and sufficient to counteract
human PKR and facilitated the gain of an adaptive
amino acid substitution in K3L that also defeats
PKR. Subsequent reductions in gene amplifications
offset the costs associated with larger genome size
while retaining adaptive substitutions. Our discovery
of viral ‘‘gene-accordions’’ explains how poxviruses
can rapidly adapt to defeat different host defenses
despite low mutation rates and reveals how classical
Red Queen conflicts can progress through unrecog-
nized intermediates.
INTRODUCTION
Rapidly diversifying host immune repertoires pose signifi-
cant barriers to successful transmission of viruses within and
between species. Many RNA viruses counter host immunity
with high mutation rates coupled with short generation times
and large effective population sizes, allowing rapid explora-
tion of mutational space for adaptation. Previous studies have
elucidated how the high mutation rates of RNA viruses are
required for tropism in animal species (Pfeiffer and Kirkegaard,
2005; Vignuzzi et al., 2006), despite driving them perilously close
to an ‘‘error catastrophe’’ threshold (Crotty et al., 2001; Vignuzzi
et al., 2005). Much less is known about the adaptive strategies of
large double-stranded DNA viruses that, despite short genera-
tion times, seem to evolve more slowly than RNA viruses (Drake
et al., 1998; Drake and Holland, 1999; Li et al., 2007; Lynch,
2010) yet comprise highly successful lineages.
The poxviruses are large double-stranded DNA viruses that
are notable because they can infect most vertebrates (chordo-
poxvirinae) and insects (entomopoxvirinae) (Harrison et al.,
2004; Moss, 2007). Poxviruses encode a large array of genes
that hijack or antagonize components of the host cell to promote
viral fitness (Bahar et al., 2011; Werden et al., 2008). Strong
natural selection at these host-virus interfaces can drive rapid
adaptations, which are reflected by the fixation of nonsynony-
mous substitutions in coding regions. These substitutions can
either enhance or weaken interactions between host and viral
factors (Emerman and Malik, 2010). The Red Queen hypothesis
postulates that such interactions evolve as an ongoing series of
counteradaptations (Dawkins and Krebs, 1979; Meyerson and
Sawyer, 2011; Van Valen, 1973). Several retrospective evolu-
tionary studies comparing the sequences of open reading
frames (ORFs) among poxvirus genomes provide ample evi-
dence of adaptive changes to overcome rapidly evolving host
defenses (Bratke andMcLysaght, 2008; McLysaght et al., 2003).
One of the most potent innate defenses against viruses is en-
coded by protein kinase R (PKR), which is activated upon
sensing double-stranded RNA that accumulates in the host cyto-
plasm during many viral infections (Weber et al., 2006). Active
PKR phosphorylates the translation initiation factor eIF2a to
inhibit protein production, which strongly impairs viral replication
(Kaufman, 2000). Antagonism by a variety of viruses over the




course of primate evolution has driven the rapid evolution of PKR
in primates (Elde et al., 2009; Rothenburg et al., 2009). As a result
of this diversification, primate variants of PKR are differentially
susceptible to inhibitors encoded by different viruses. Vaccinia
virus encodes two such antagonists, K3L and E3L, which each
specifically inhibit PKR by distinct mechanisms in different
species (Davies et al., 1993; Langland and Jacobs, 2002). The
rapid evolution of PKR has led to species-specific resistance
to K3L among primates.
A partial explanation for flexibility in poxvirus host range is
provided by several ‘‘host-range’’ factors, like K3L and E3L,
which can overcome species-specific blocks to infection.
Left unanswered, however, is the fundamental question of how
poxviruses, despite their low mutation rate, efficiently explore
mutational space and overcome rapidly evolving immune
factors, such as PKR, as they move between host species. For
example, some poxviruses, such as cowpox, vaccinia, and
monkeypox, infect both animals and humans in zoonotic infec-
tions, with the latter cases being of considerable biomedical
importance. The fact that these viruses can infect divergent
host species despite diverse mechanisms of immunity suggests
that they employ different means of evolutionary adaptation from
those known for rapidly evolving RNA viruses to overcome low
mutation rates. Moreover, even within the same host popula-
tions, poxviruses must adapt rapidly to persist despite lowmuta-
tion rates. Gaining insight into the currently unknown basis of
adaptation in this biomedically and evolutionarily important class
of viruses is essential for understanding how these viruses infect
a wide range of hosts.
Fundamental insights into evolutionary mechanisms have
been derived from laboratory and experimental evolution of
various microbial populations (Beaumont et al., 2009; Meyer
et al., 2012; Montville et al., 2005; Vignuzzi et al., 2006; Wichman
et al., 1999). To date, however, nearly all protocols involving
experimental evolution of viruses have used strains with high
mutation rates (e.g., small RNA viruses) and/or ones that quickly
generate large effective population sizes under laboratory condi-
tions (e.g., bacteriophages). Here, we devised an experimental
evolution protocol to determine how poxviruses adapt using
serial vaccinia infections at relatively small population sizes. By
passaging a vaccinia strain deleted for the host range gene
E3L, we mimicked a host-switching event, which placed strong
selective pressure on K3L to inhibit the antiviral PKR. Our
studies reveal mechanisms of poxvirus adaptation to defeat
host defenses via rapid episodes of transient gene amplification.
This simple and recurrent mechanism of adaptation on a
genomic scale also reveals a new general model for mitigating
fitness costs associated with large changes in genome structure.
Our experiments not only reveal an important means by which
poxviruses adapt but also highlight a mechanism by which
radical adaptations might be explored in many organisms that
have large genomes and low mutation rates.
RESULTS
Experimental Evolution of Vaccinia Virus Reveals
Adaptation by Gene Expansion
Weused the fact that K3L from vaccinia virus is a poor inhibitor of
human PKR to determine how poxviruses can adapt to over-
come an initially insurmountable host defense. By starting with
the Copenhagen strain of vaccinia virus deleted for E3L (DE3L)
(Beattie et al., 1995), we placed strong selective pressure on
K3L (Figure 1A). Three replicate virus populations were repeat-
edly propagated in HeLa cells at a low multiplicity of infection
of 0.1 plaque-forming units/cell. After 48 hr of infection, we
collected the virus, measured titers, and repeated the protocol








































Figure 1. Experimental Evolution of Vaccinia Virus
(A) Vaccinia encodes two host-range factors, E3L and K3L, that inhibit antiviral
protein kinase R (PKR).
(B) Vaccinia DE3L was repeatedly passaged through HeLa cells in triplicate
(see Experimental Procedures). After each infection, virus titer was measured,
an aliquot was reserved for the ‘‘fossil record,’’ and fresh cells were infected.
Red dots represent viruses in which a theoretical adaptation arises in the
population and increases in frequency.
(C) With passaging of DE3L virus, replicate populations A–C gained the ability
to replicate in HeLa cells as judged by viral titers assayed over the course of the
experiment. Dotted horizontal lines show the average titer of parental virus
(DE3L) and the wild-type Copenhagen strain of vaccinia (WT). Because E3L
was replaced by lacZ, we could also use b-gal activity assays as a proxy for
measuring virus replication (inset). Gains in replication were corroborated by
measurements of b-gal activity, shown in arbitrary units, from parental virus
and replicates A–C at passage 10 (p10; inset). Data are represented as
mean ± SEM.




DE3L virus initially replicated much less efficiently than wild-
type virus in HeLa cells, consistent with previous reports (Lang-
land and Jacobs, 2002). By six rounds of passaging in HeLa
cells, each of three replicate virus populations consistently
produced 10-fold more infectious viruses than the parental virus
strain as measured by plaque assays (Figure 1C) and b-gal
activity assays (Figure 1C, inset). Further gains in virus produc-
tion were not evident during the remaining four passages.
Thus, despite a low mutation rate, and relatively small effective
population sizes starting at 5 3 105 viruses/passage, all three
replicates of vaccinia rapidly gained increased fitness over the
course of passaging.
To determine the genetic basis of rapid adaptation, we per-
formed deep sequencing of all virus populations to approxi-
mately 1,000-fold genome coverage. We found only two nonsy-
nonymous and one synonymous polymorphism in the genomes
of passage 10 virus replicates at a frequency higher than 1%
(Figure 2A). This paucity of mutations highlights the low rate of
nucleotide substitution in vaccinia genomes. In addition, none
of the substitutions were found at high frequency or in all repli-
cates. In contrast, by scanning sequencing coverage among
mapped reads, we found a substantial spike in relative depth
that mapped exclusively over the K3L gene, which is consistent
with a striking increase in copy number of the K3L locus in all
three replicate strains (Figure 2A). The increased read-depth
corresponds to an average of three (replicates A, C) to four (repli-
cate B) copies of K3L per viral genome (Figure 2A).
To further determine the character of these K3L expansions,
we performed Southern blot analysis of viral genomes sampled
from points throughout the passaging protocol, using the K3L
gene as a probe. These analyses revealed a highly heteroge-
neous pool of viral genomes in each replicate, with some
harboring 15 or more copies of K3L by passage 10 (Figure 2B).
Intriguingly, the appearance of multiple copies of K3L paralleled
the pronounced increases in virus replication, which occurred by
passage 4 for both replicates A and C, and passage 6 for repli-
cate B (compare Figures 1C and 2B). Therefore, increased
copy number of K3L directly correlated with increased viral
fitness. Additional analysis of discordantly mapping paired-end
reads revealed a complex pattern of duplications at the K3L
locus exclusive to the adapted strains (Figure 2C; Figure S1
available online; Table S1). Notably, analysis of the duplication
break points confirmed the independent origins of the K3L dupli-
cations in each of the three replicate populations of adapted
vaccinia viruses.
Resequencing of parental genomes to nearly 1,000-fold
coverage failed to reveal any pre-existing duplications of K3L
in this homogenous virus population (Table S1). PCR confirmed
the independent emergence of tandem duplications of K3L at
several distinct break points in the genes adjacent to K3L in
the evolved populations. In addition to our initial experiment,
three additional DE3L virus replicates passaged under the
same conditions all yielded expansions of K3L as judged by
PCR to detect K3L-associated break points (Figure S2), demon-
strating the reproducibility of gene amplification as a means of
adaptation.
To determine if genomic amplification of K3L accounted for
enhanced viral replication, we first compared K3L protein
expression between parental and passaged viruses (Figure 3A).
Each passage 10 replicate expressed considerably more K3L
protein than even wild-type virus, which still replicates more effi-
ciently than any of the adapted strains because of the presence
of E3L (Figure 3A). To determine whether overexpression of K3L
alone is sufficient to explain the robust increase in viral fitness,
we specifically knocked down K3L expression using siRNA
transfections. Successful knockdown of K3L reduced virus repli-
cation to levels indistinguishable from prepassaged, parental
DE3L virus (Figure 3B). Therefore, K3L copy number amplifica-
tion was necessary and sufficient for increased expression
of K3L, which caused the substantial gain in virus fitness we
observed. Because K3L mimics PKR’s substrate eIF2a and
inhibits PKR by direct binding (Dar and Sicheri, 2002), it appears
that an increased abundance of even weakly active K3L antago-
nizes PKR by mass action, providing the basis for an immediate
evolutionary advantage due to genomic expansion.
Acquisition of an Adaptive Substitution following Gene
Expansion
Whereas K3L copy number amplification provided a rapid, recur-
rent basis for adaptation in all of the replicate populations, most
studies of virus evolution identify adaptive point mutations as
the basis of fitness gains. We found that two of the replicates
from our study possessed a single amino acid substitution,
H47R, in K3L at frequencies of 3% and 12% (Table S2). Remark-
ably, this exact substitution was previously identified in a genetic
screen for K3L mutants with enhanced activity against human
PKR using a yeast assay interrogating the K3L-PKR interaction
(Kawagishi-Kobayashi et al., 1997). We isolated this variant
from the adapted passage 10 replicate C vaccinia population
containing a single copy of K3L with the H47R mutation and
tested its fitness relative to viruses with gene expansions of
wild-type K3L sequence. Both the single copy H47R-bearing
virus and the multicopy K3L virus had marked improvements in
fitness over the parental single-copy wild-type K3L virus (Fig-
ure 3C). These findings also strongly support the idea that fitness
gains realized by K3L amplification and acquisition of H47R in
serially propagated virus populations reflect specific antagonism
of PKR. In addition, although only 12% of the K3L genes at
passage 10 of replicate C contain the H47R mutation (541 reads
out of 4,146 total sequencing reads), 47% of single-copy K3L
genes from the same virus population harbor this substitution
(24 cases with H47R out of 51 K3Ls sampled via PCR and
sequencing; p < 0.0001, Fisher’s exact test). This result implies
that low copy number viruses are strongly selected to possess
the adaptive H47R allele of K3L compared to K3L expanded
viruses in the same pool. Thus, our experimental evolution
strategy uncovered two responses to the same selective chal-
lenge: adaptive copy number expansions seen in all replicate
populations and an adaptive nonsynonymous mutation seen at
low frequency in two of three replicates.
The emergence of the H47R substitution raised the possibility
that K3L expansions facilitated the appearance of the variant by
providing additional targets for mutation to generate increased
variation, including beneficial substitutions, like H47R. Examina-
tion of parental DE3L strain sequences mapping to codon 47 of
the K3L coding region failed to reveal H47R in the starting
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Figure 2. Rapid Evolution of Copy Number Amplification
(A) Genomic DNA traces of parent and virus replicates A–C at passage 10, showing relative depth of sequence coverage across the entire !180 kb vaccinia
genome, except for the inverted terminal repeat regions (ITR; ITRs are shown in Figure S4). Increased K3L sequence coverage was observed in replicates A–C
(upper-right; also see Figures S1 and S2), whereas coverage of E3L was missing in all populations (lower-right). Polymorphisms were detected in the K3L, E9L,
and H2R genes as indicated (also see Table S2). We also detected 15 nucleotide differences between the parent and reference Copenhagen strain, which were
unrelated to our protocol (Goebel et al., 1990) (Table S6).
(B) Southern blots of the K3L locus of viral replicates A, B, and C during the course of experimental evolution from passages 1–10 reveal rapid gene copy number
amplification of K3L. Amplification may be a consequence of recombination-driven tandem duplications (Figure S3).
(C) Diagrammed is the parental K3L locus and the major duplication break points near K3L that led to copy number amplification (also see Table S1). We also
found duplications at the highly repetitive termini of the vaccinia genomes, consistent with previous observations (Moss et al., 1981) (see Figure S4). However,
these terminal expansions were also present in the parental strain and therefore not a consequence of our experiments.




population (Table S2). Also consistent with K3L expansions
preceding the acquisition of H47R was our observation that
replicate B, the slowest population to undergo K3L amplification
(Figure 1C), lacked any detectable H47R K3L alleles by pass-
age 10. Together, these data suggest that H47R appeared after
K3L gene expansion.
To determine when H47R emerged during the course of
passaging, we amplified K3L from genomic samples of replicate
C at each passage point and sequenced amplicon populations.
K3L expansions, as judged by PCR amplification across K3L
duplications, preceded the appearance of the H47R substitution
during viral passaging (Figure 4). Sequencing of PCR products
spanning K3L duplications at late passage points revealed
the presence of H47R in both single and multicopy K3L arrays.
We further sampled the composition of multicopy arrays by
sequencing 34 clones bearing two K3L gene copies. Of these,
ten had both wild-type and H47R-containing copies of K3L.
Together, these data strongly suggest that K3L expansions
facilitated the emergence and increased frequency of the
H47R substitution. Thus, not only are the K3L gene expansions
immediately advantageous because of their ability to provide
enhanced antagonism of human PKR but they also facilitate
the acquisition of single Darwinian ‘‘gain-of-function’’ changes
by increasing the number of mutational targets despite an other-
wise modest mutation rate.
A General Mechanism of Gene Expansion in Vaccinia
Genomes
Two previously proposed mechanisms could account for facile
gene expansion in vaccinia genomes. One study proposed un-
equal crossover as a mechanism to account for variation in





































































Figure 3. Overexpression of K3L Protein in
Adapted Strains Is Necessary and Sufficient
for Increased Viral Fitness
(A) Western blot analysis of vaccinia and mock-
infected HeLa cells with wild-type (WT), parental
(DE3L), and virus replicates A–C at passage 10 for
levels of K3L, vaccinia proteins, and actin.
(B) siRNA knock down of K3L in infected
HeLa cells. Viral replication wasmeasured by b-gal
activity assay of virus and mock-infected cells
transfected with K3L-specific siRNAs (1–3) or a
nontargeting control. Western blot shows levels of
K3L, vaccinia proteins, and actin.
(C) b-gal activity from HeLa cells infected with
various vaccinia viruses. Wild-type vaccinia virus,
DE3L parental virus, and passage 10 virus from
replicate C were compared to plaque-purified
clones with either a single copy H47R-K3L (1),
a single copy WT-K3L (3), or a multicopy K3L virus
with both WT and the H47R substitutions (2).
Numbers correspond to plaque-purified viruses
described in Figure 6. Data are represented as
mean ± SEM.
genome (Moss et al., 1981). A second
study pointed to the possibility that
gene expansions could occur episomally,
because vaccinia can promote rapid amplification of nonviral
plasmids. To determine whether the K3L locus was being
expanded by a mechanism involving episomes containing K3L,
we used RecBCD enzyme, a complex helicase and nuclease,
which rapidly digests all linear genomic DNA but spares any
potential circular episomes (Eichler and Lehman, 1977; Smith
et al., 1995). Southern blot analysis of undigested genomes, as
well as those treated with RecBCD to eliminate linear DNA forms
that might have otherwise obscured circular forms, failed to
reveal the presence of circular DNA intermediates containing
K3L in genomes of viruses passaged in HeLa cells (Figure S3).
Thus, we can exclude an episomal mode of amplification, which
suggests that recombination-driven K3L gene expansions within
linear genomes of each replicate virus account for the rapid
adaptation of vaccinia virus.
Recombination-mediated gene expansions, which can facili-
tate the acquisition of adaptive substitutions, could represent
a general mechanism for rapid adaptation of poxviruses. To
determine if gene duplications similar to K3L were present at
low frequency in virus populations, we assayed for the presence
of additional duplications in virus populations. Twelve sets of
PCR primers were designed to amplify products across potential
duplication break points at locations spaced roughly evenly
throughout the genome (Table S3). These probes for duplica-
tions were used to query three vaccinia strains (Western
Reserve, Copenhagen-VC2, and the parental strain used in this
study, Copenhagen-VC2-DE3L). Despite our limited sampling,
we found that each strain harbored at least one duplication break
point in virus populations (Figure 5). We did not detect any
shared sequence motifs or consistent patterns of homology at
sites in which duplications arose that might promote genomic
expansions. However, each of the duplications we uncovered




maps toward the distal regions of the vaccinia genome, which
have a higher frequency of recombination and are comprised
of many genes that are dedicated to the modulation of host
factors (Moss, 2007). In contrast, genes toward the center of
the vaccinia genome are essential for virus-specific functions
in the cytoplasm of the host cell. Four of the twelve primer sets
tested amplified duplications in the Western Reserve strain,
which included several break points from duplications of K3L
(Table S4). Further examination of deep sequencing reads also
revealed rare duplication break points that were confirmed for
two cases by PCR in populations of adapted strains at genomic
locations outside the K3L locus (Table S5). These data reveal
that virus populations contain a variety of low-frequency break
points that could rapidly seed genomic expansions under suit-
able selective conditions, such as changing hosts. Much like
random nucleotide substitutions that can start adaptive sweeps
driven by selection, we propose that these low-frequency dupli-
cation events across the vaccinia genome can drive rapid gene
expansions to overcome host defenses, followed by expanded
sampling of point mutations. Given the low rate of nucleotide
substitutions uncovered by our sequencing analyses, the
frequency of these duplications may be on par with or exceed
the frequency of nucleotide substitutions, as has been previously
observed in some eukaryotic genomes (Lipinski et al., 2011;
Lynch et al., 2008).
Genomic Accordions Reveal Tradeoffs Associated with
Genomic Expansion
K3L copy number expansions represent a significant increase in
vaccinia genome size. Although comprising a minor fraction of
the population, viruses harboring 15-fold amplifications of K3L
have genomes 7%–10% larger than the parental strain (Fig-
ure 2B). Vaccinia can package similarly sized genomic additions
with a seemingly negligible impact on replication efficiency
(Smith and Moss, 1983), but poxvirus genomes also undergo
adaptive size reductions under a variety of conditions (Hendrick-
son et al., 2010; Meisinger-Henschel et al., 2007). Therefore, to
determine if there was an evolutionary tradeoff associated with
large genomic expansions of K3L, we removed selective pres-
sure from amplifications of K3L. Unlike in human cells, single
copy K3L from vaccinia virus defeats PKR in BHK (hamster) cells
(Figure 6A) (Beattie et al., 1995; Langland and Jacobs, 2002);
therefore, passaging virus in these permissive cells directly tests
whether the expansions incurred a fitness tradeoff.
We plaque-purified nine vaccinia clones from the population of
passage 10 viruses from replicate C by passaging four times in
BHK cells. Southern analyses of these viral genomes revealed
that these viruses contained either only a single copy of K3L or
nearly identical multicopy arrays with considerably fewer copies
of K3L compared to passage 10 viruses from HeLa cells (Fig-
ure 6B). To rule out the possibility that secondary genetic
changes had caused contraction of the K3L expansions, we re-
introduced selective pressure on one of the plaque-purified
multicopy K3L viruses (5*) with four additional passages in
HeLa cells. Reapplication of selective pressure led to a clear
increase in K3L copy number compared with passaging the
same viruses in BHK cells (Figure 6C). Thus, removing the selec-
tive pressure that led to gene amplification resulted in a repro-
ducible and reversible reduction in K3L locus expansion, consis-
tent with there being a fitness cost associated with the genomic
expansions. Alternatively, it is possible that simply relaxing
C20L C3L
K3L



































Figure 5. Low-Frequency Gene Duplications in Vaccinia Genomes
Of the primers tested (Table S3), duplications at several loci near the termini of
the genomewere amplified and sequenced (Table S4). Break-point regions are
drawn to scale, highlighting the location of each duplication point. One break
point observed in K3L leads to a fusion product in place of the wild-type copy.
The C20L and B26R regions are mirrored at each end of the chromosome,
such that the reported break points could be at either end of the genome.
Additional low-frequency duplications were detected in deep sequencing








Figure 4. K3L Expansions Precede the Appearance of the H47R
Substitution
PCRwith genomic samples from the ‘‘fossil record’’ of replicate Cwith primers
amplifying duplications of K3L is consistent with Southern blot analysis.
Sequencing of duplicated K3L regions reveals that the appearance of the
mutation leading to the H47R substitution is only appreciable after duplications
of K3L appeared.




selective pressure for K3L expansion leads to a relative loss of
K3L because of a bias in which recombination-driven losses
exceed gains. It is notable, however, that replicate B virus pop-
ulations lacking the H47R substitution continue to show ongoing
increases in K3L copy number at passage 10 as judged by
Southern analysis (Figure 2B). This suggests that copy number
of K3L may continue to expand until a beneficial mutation
provides an adaptive alternative to genomic expansion.
DISCUSSION
Our experimental evolution studies of vaccinia evoke a ‘‘gene
accordion’’ model for genome evolution. Localized genomic
regions transiently expand to enhance levels of gene expression,
while simultaneously providing additional gene copies for sampl-
ing mutational space (Figure 7). Subsequent contractions
mitigate the costs of replicating larger genomes while retaining
adaptive alleles like H47R, which arose during the expansion.
Thus, a simple mechanism of recombination-driven genomic
expansions and contractions facilitates the rapid evolution of
virus populations with otherwise low mutation rates.
Gene accordions do not appear unique to the K3L locus. In
addition to the low-frequency duplications we detected in
vaccinia genomes (Figure 5; Table S4), this model of adaptation
through intermediates of transient gene expansion also helps
explain a variety of previous observations in the genomes of
large double-stranded DNA viruses, including ancient gene
family expansions among several poxviruses (McLysaght et al.,
2003) and herpesviruses (Searles et al., 1999), chemically


























































Figure 6. Evolution of Transient Copy
Number Amplification
(A) b-gal activity from BHK cells infected with
parent virus (DE3L) and replicates A–C at passage
10. Data are represented as mean ± SEM.
(B) Southern blot of the K3L locus from plaque-
purified vaccinia viruses obtained from serial
plaque purification of passage 10 replicate C virus
in BHK cells. The presence or absence of the H47R
substitution in K3L is indicated for each strain.
(C) Southern blot of multicopy plaque-purified
virus (clone 5* from B) after four additional pas-
sages (+4p) in BHK or HeLa cells. Viruses
passaged in HeLa cells showed re-expanded K3L
copy number relative to those passaged in BHK
cells.
1986; Slabaugh et al., 1989), and a poten-
tially adaptive duplication observed in the
myxoma poxvirus (Kerr et al., 2010). A
particularly clear example of such adap-
tive gene expansions is evident in the
genomes of avipoxviruses, which devote
as much as 30% of the genome to a small
set of large gene families that includes
many ankyrin repeat-containing genes
(Afonso et al., 2000). Avipoxviruses illus-
trate an exceptional example of gene
duplications facilitating neofunctionalization of individual copies
of the amplified gene family, leading to the retention of multiple
variants rather than contraction back to a single copy. We
propose that sampling a reservoir of low-frequency duplications
at various genomic regions in the virus population reflects an
underappreciated but common mechanism seeding dynamic
and adaptive gene expansions in these viruses. Our observa-
tions reveal that such viruses adapt to new, hostile host environ-
ments first by rapid gene expansion rather than gene mutation.
These results also reveal that a strength of the experimental
evolution strategy is its power to reveal important evolutionary
intermediates that could be too fleeting to capture by less
frequent sampling or missed all together by studying viruses
long after host switches. For example, we could clearly demon-
strate that vaccinia genomes underwent a specific K3L gene
expansion that exactly correlated with all fitness gains observed
during our experiment. However, by ten passages the K3L gene
had already been replaced by the H47R variant in 12% of all K3L
genes in one of the replicates. Sampling at a later point could
conceivably obscure the accordion-like origins of an H47R-like
adaptation as the variant sweeps through the population and
replaces large and costlier gene expansions. This duality of
adaptation might also be reflected in the different stages of viral
transmission between species, including zoonosis. Gene expan-
sions might be favored early in infection when most viral adapta-
tion is centered on overcoming host defenses, as was modeled
by our experiment. At later stages of infection, gene expansions
are likely to be strongly selected against as viruses compete not
only against the initial challenge imposed by host defenses but
also against larger populations of fit viruses carrying the




equivalent of an H47R mutation. Future studies will be important
to assess not only the generality of this adaptive mechanism but
also to compare the dynamics observed in our experiments to
those that occur during natural poxviral infections.
Despite the rapid gene expansions observed in our study,
very few poxviruses sequenced from the wild have been found
to harbor recent gene duplications or expansions, with the an-
kyrin repeat genes in avipoxviruses being a clear exception.
Although some expansions may be obscured by subsequent
contractions, it is also possible that many expansion events
have been missed because of an ascertainment bias. Until
recently, sequencing methodologies rarely accounted for
copy number variation as a source of genetic heterogeneity.
Indeed, sequencing of different strains of variola (smallpox)
virus with the aim of determining how variola major had a higher
fatality rate than variola minor focused primarily on nucleotide
substitutions, which revealed less than 2% divergence (Espo-
sito et al., 2006). Although this genetic divergence might be
sufficient to explain differential pathogenicity, important
instances of copy number variation might have gone unde-
tected in these comparisons. New sequencing technologies
greatly increase the prospects of capturing such intermediate
states from poxviruses that have undergone minimal passaging
in the lab.
Our study also highlights the important role that gene copy
number expansion plays in adaptation of genomes with low
mutation rates. This mode of adaptation may be especially prev-
alent when an immediate advantage can be gained via mass
action. Examples include selection for resistance to drug thera-
pies against cancer (Drummond et al., 1997; Schimke, 1986), for
enhanced enzymatic degradation of toxins (Sandegren and
Andersson, 2009), or for overcoming a host antiviral protein,
like PKR. In these cases, the duplication event is itself nonneutral
and can be further acted upon by recombination to drastically
alter genome architecture. Whereas rapid evolution of copy
number variation is known for some nonvirus microbial popula-
tions, including Plasmodium, yeast, and a variety of bacteria
(Bergthorsson et al., 2007; Demuth and Hahn, 2009; Dunham
et al., 2002; Kugelberg et al., 2010; Nair et al., 2008; Pra¨nting
and Andersson, 2011; Stambuk et al., 2009; Sun et al., 2009),
adaptation via gene expansion in poxviruses represents an
unappreciated mechanism of evolution in this large, medically
relevant class of DNA viruses (Harrison et al., 2004). In the cases
cited above, copy number expansions may also be poised
for adaptive contractions that unfold on longer time scales,
thus obscuring the ‘‘genomic-accordion’’ mechanism revealed
here by vaccinia virus (but also see Pra¨nting and Andersson,
2011).
Some of the passage 10 viruses we assayed have a 7%–10%
expansion in genome size purely by virtue of a single gene
expansion. In a 200 kb genome, this is a noteworthy adaptation
for its major alteration of genomic structure. Our findings
also indicate that a diversity of adaptive strategies—copy
number variation in addition to nucleotide substitution—falls
well within the viral kingdom. It seems likely that this mode
of adaptation is applicable to many other viruses that have
similarly low mutation rates and relatively limited restrictions on
genome size. Exceptions are likely to be viruses that have low
mutation rates but strict limits on genome size because of
a highly constrained capsid structure (e.g., adenoviruses and
certain bacteriophages). It will be informative to determine
whether other large DNA viruses, like herpesviruses, which
replicate in the nucleus and also show evidence of gene expan-
sions (Searles et al., 1999), follow similar gene-accordion
dynamics as the poxviruses, which replicate in the cytoplasm
of host cells.
There are striking parallels between the challenges imposed
on viruses by exposure to new batteries of innate defense genes
and the challenges imposed on organisms adapting to strong
selective pressure, like bacteria grown under stress-inducing
conditions (Andersson et al., 1998; Cairns et al., 1988; Foster,
1994; Hastings et al., 2000; Hendrickson et al., 2002). In each
of these cases, a significant step in the adaptive process
involves rapid and short-lived gene expansions that permit the
selection of ‘‘escape’’ variants. Our study thus reveals a previ-
ously unappreciated insight into the dynamics of Red Queen
conflicts between pathogens and hosts (Elde and Malik, 2009;
Emerman and Malik, 2010; Meyerson and Sawyer, 2011). Tradi-
tionally viewed primarily as substrates for rapid selection of
nonsynonymous codon substitutions, these interactions may
also depend on adaptive gene amplifications that are overlooked
because of their transience or difficulty of detection (Figure 7).
Indeed, ‘‘gene-accordions’’ may be a critical feature of many
genetic conflicts involving strong selection.
EXPERIMENTAL PROCEDURES
Viruses and Reagents
The VC2 (wild-type) Copenhagen strain of vaccinia virus and the E3L deletion
mutant (DE3L), with the lacZ gene replacing E3L, were a gift from B. Jacobs
(Beattie et al., 1995). HeLa and BHK cells were cultivated in Dulbecco’s
modified Eagle’s medium (DMEM) + 10% Nu serum (BD Biosciences, Franklin
Lakes, NJ, USA).
Experimental Evolution of Vaccinia Virus
For each passage of vaccinia, 100mm dishes were seeded with a fresh aliquot
of HeLa cells in triplicate (5 3 106 cells/dish). Cells were infected with DE3L
virus at a multiplicity of infection of 0.1 pfu/cell. After 48 hr, infected cells
were pelleted and washed, and viruses were harvested by three freeze/thaw
cycles in a mixture of dry ice/ethanol and were resuspended in 1 ml of
Figure 7. Genomic Accordion Model of Poxvirus Evolution
The model depicts Red Queen conflicts proceeding through ‘‘gene-
accordion’’ intermediates. Gene copy number amplification provides an im-
mediate fitness advantage and additional gene copies for sampling potentially
beneficial mutations. After acquisition of a beneficial mutation, virus genomes
are selected that retain advantageous point mutations without the gene
expansion, leading to contractions down to a single gene copy.




DMEM + 10% Nu serum. Viral titers were calculated by performing plaque
assays in BHK cells between each passage. After ten passages, aliquots of
virus reserved from each passage were expanded with a single 48 hr infection
of BHK cells and viral titers were determined. To evaluate the replication prop-
erties of these viruses, triplicate wells of HeLa cells were infected at 0.1 pfu/cell
using viruses from every other passage and viral yield was measured by
titering cell lysates made at 48 hr postinfection. b-gal activity was determined
with 4-methylumbelliferyl-b-D-galactopyranoside (MUG) fluorescence assays
(Hakki and Geballe, 2005). Genomic DNA was prepared as previously
described (Esposito et al., 1981) from viruses obtained at every passage of
the protocol.
Deep Genome Sequencing of Vaccinia Strains
Illumina sequencing libraries were prepared from genomic DNA from parental
DE3L virus and each replicate (A–C) at passage 10 using the Nextera se-
quencing library construction kit (Epicentre Biotechnologies [Illumina, Inc.],
Madison, WI, USA). Multiplexing barcodes were added by PCR as previously
described (Adey et al., 2010). Barcoded libraries were combined and
sequenced across three lanes on Illumina GA-IIx and HiSeq 2000 instruments.
Reads were mapped to the vaccinia reference genome with bwa version
0.6.1 (Li and Durbin, 2009); custom python scripts were used to calculate
read depth and find break-point junctions.
Plaque Purification of Vaccinia
BHK cells were infected with dilutions of passage 10, replicate C virus. At
!2 days postinfection, cells were collected from isolated individual plaques,
diluted into medium, and lysed by three cycles of freezing and thawing.
Dilutions of these first round plaque-purified viruses were used to infect fresh
BHK cells, and the process was repeated three more times. After the fourth
round of plaque-picking, a stock of each plaque-purified virus was prepared
in BHK cells and was used for infections to assess replication and to make
viral DNA.
RecBCD Digests
Vaccinia replicate C genomes harvested after 10 passages were first digested
with restriction enzymes recognizing sites near K3L break points (EcoRV),
within K3L (BstZ17I), at sites distant from K3L (SacI), or left intact. Samples
were incubated with five units of RecBCD ±125 mMATP based on a previously
reported method (Eichler and Lehman, 1977) but with a modified reaction
buffer containing 1 mM DTT, 20 mM potassium phosphate, and 10% glycerol.
Samples were incubated twice for 2 hr at 37"C with five additional units of
RecBCD added between incubations. Genomes were resolved by agarose
gel electrophoresis at 80 V for 10 hr and Southern blots were performed as
described in the methods.
Southern and Western Blot Analysis
For Southern blots, 2–5 mg of vaccinia genomic DNA was digested with EcoRV
or BspEI (New England Biolabs, Ipswich, MA, USA). Genomes were resolved
by agarose gel electrophoresis, DNA was transferred by capillary action
and UV-cross-linked to nylon membranes (Nytran SuPerCharge; Whatman
[GE Healthcare Biosciences], Pittsburgh, PA, USA). Probes of PCR-amplified
K3L, or an adjacent genomic region, were generated by biotin random prime
labeling, hybridized, and bands detected with a North2South Chemilumines-
cent detection kit (Pierce [Thermo Scientific], Rockford, IL, USA).
For western blots, cells were infected with vaccinia for 48 hr and whole-cell
lysates were collected in 2%SDS. Proteins were resolved by SDS-PAGE (12%
Tris-glycine gel; Invitrogen, Carlsbad, CA, USA) and transferred to nitrocellu-
lose membranes (Pierce). Proteins were detected with anti-K3L antibody
(1:2,000; gift from J. Tartaglia), serum from rabbits infected with vaccinia
virus (1:1,000; gift from B. Moss), and antiactin antibody (1:1,000; Abcam,
Cambridge, UK).
siRNA Knockdown of K3L
Three double-stranded siRNAs were designed to target expression of K3L
(1: 50-aagauaaauguauagagcauaaucc(uu)-30; 2: 50-uucaacauaucuauccauaug
cauc(uu)-30; 3: 50-uauaaucaacucuaaucacuuuaac(uu)-30; IDTDNA). HeLa cells
were transfected with one of the siRNA molecules (10 nM) or a nontargeting
control siRNA that has at least four mismatches to all ORFs from several
genomes (Dharmacon[Thermo Scientific]) using Lipofectamine 2000 (Invitro-
gen). Twenty-four hours after transfection, cells were infected with vaccinia
for 48 hr. Expression of K3L was measured by western blot and b-gal activity
was measured as a proxy for virus replication.
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Table S1. Genome Amplification Break Points in Replicates of Vaccinia Virus near 






A* B* C* parent*** 
1 31,725 30,296 1,757 2 3 0 
2 31,573 28,284** 0 338 1 0 
3 30,837 30,284 6 2,444 1,938 0 
4 30,840 30,287 5 2,269 202 0 
total aligned reads: 4.5E+06 5.9E+06 3.7E+06 1.7E+06 
break = breakpoint coordinate in reference genome (K2L ORF 29204..30313, K4L ORF 
30681..31955) 
* number of sequencing reads with breakpoint (multiplexed sequencing run) 
** breakpoint occurs upstream of K2L ORF in K1L 
















Table S2. Polymorphisms in Vaccinia Virus Populations from Experimental 
Evolution, Related to Figure 2 
 
gene variant sub. parent* A* B* C* 
























syn = synonymous substitution 
* Showing a ratio of reads with the polymorphism to total reads. A 1% frequency cut-off 
was used to account for potential barcode misassignment in the multiplexed sequencing 



































Table S3. Duplication-Specific Primers at Locations across Vaccinia Genomes, 




Coord.* Reverse  
primer 
Coord.* 
C20L** GAT AGG TTC GAC ATT 
CAG AAA GAC G 
6,874-
6,850 
GTT GAA GGT AAG 
TGT GTA ACC GC 
7,093-
7,115 
C3L CTC CAG GAA ATA CAT 
GGA AGC CG 
21,806- 
21,784 
CGC ATC CTA TTC 
CCA ACA ATG TC 
22,503- 
22,525 
K3L GGG ATA AAC TGG 




CAG AGT GAG GAT 
AGT CAA AAA GAT 
AAA TGT ATA G 
30,521-
30,554 
F13L GAG ATT GGG TAT CTA 
GCC ACA GTA 
44,001-
43,978 
TTC TAC CAG CCT 
ACA TTT TGC TCC 
45,029-
45,052 
I7L CGT ATG GAA AAA 
TGG ACC AAA AAG TC 
68,886-
68,861 
CAT CTA TAT TGC 




J2R GAT ATG TAT CAA TCG 
GTG TGT AGA AAG TG 
84,344-
84,372 
CTG TAC TTT TAC 
CTG AAA ACA TGG GG 
83,912-
83,887 
D5R GCC AAT GTT AGT GAT 
GAA TAT CTG CA 
103,718-
103,743 
CCT CGA TAA TAA 




A4L GGG CAA TAG ATC 




GGT GTA GAG GAT 
TCT GCC AGC 
117,221-
117,241 
A29L AAG CAT TGT CTG ATG 
CGT GTA A 
139,824-
139,803 
GTT CGA GTT CAA 
CGA CGA TTG A 
140,644-
140,665 
A52R GGA GAA ATG AGA 




TTT CCC TCC TAG 
TAG TCA CCG 
157,820-
157,800  
B20R GAA ACA CAA GAT CAA 
AGT ACA CAA CAC A 
179,645-
179,672 
TCG GTG AGA TAC 




* ‘L’ ORFs coordiate numbers based on complement sequence, Copenhagen strain 


















Table S4. Sequenced Duplications in Vaccinia Strains, Related to Figure 5 
 
ORF (strain) ‘right’ break* ‘left’ break* Fully duplicated ORFs 
C20L (WR) 7,345 6,659 C20L 
C3L (WR) 22,675 21,741 C3L 
K3L (WR) 30,738 30,261 K3L 
K3L (WR) 30,587 30,399 - 
B20R (VC2) 179,726 179,121 B20R 
B20R ('E3L) 179,905 179,025 B20R 
B26R** (WR) 185,174 184,579 B26R 
* genomic coordinates from vaccinia Copenhagen reference (Genbank M35027) 





































Table S5. Nonrecurring Genomic Break Points Consistent with Duplications, 
Related to Figure 5 
 
virus strain ‘right’ break* ‘left’ break* inferred duplicated ORFs 
'E3L parent 156,405 143,153 A35R - A49R 
'E3L parent 162,444 22,338 large genomic block 
A 31,413 30,525 -** 
 A 67,627 66,482 -*** 
A 104,930 34,700 large genomic block 
A 107,526 107,330 - 
B 29,837 22,298 C1L, N1L, N2L, M1L, M2L, K1L 
B 47,387 24,975 N2L, M1L, M2L, K1L-K7L, F1L-F17L**
B 47,467 25,066 N2L, M1L, M2L, K1L-K7L, F1L-F17L**
B 55,156 55,104 - 
B 141,790 141,697 - 
B 169,683 168,828 B7R 
C 24,505 23,524 - 
C 90,475 87,550 ‘H orf A’*** 
C 104,395 104,298 - 
C 167,515 89,039 large genomic block 
C 171,274 100,726 large genomic block 
* genomic coordinates from vaccinia Copenhagen reference (Genbank M35027) 
** includes K3L 

























Table S6. Vaccinia Virus Genome Comparison between 'E3L and Copenhagen 











16,033 A G 98.6 intergenic - 
23,443 C T 99.8 C2L syn 
24,256 G C 100.0 C1L syn 
25,525 G C 100.0 N2L P121R 
35,080-1 CG GC 99.3 F3L T313S 
44,312 A G 99.6 F13L syn 
46,742-3 CG GC 99.2 F16L R10A 
77,258 A T 99.9 G7L V348E 
81,834 G A 99.6 L3L L1384F 
85,139 T C 99.8 J3R V209A 
104,656 C T 99.5 D6R T180M 
114,376 - C 88.4 intergenic - 
145,839 T A 97.2 intergenic - 
148,904 A T 99.7 A41L syn 
152,699 - C 81.2 A46R frameshift








EMERGENCE OF A VIRAL RNA POLYMERASE VARIANT  
DURING GENE COPY NUMBER AMPLIFICATION  
PROMOTES RAPID EVOLUTION OF 
VACCINIA VIRUS 
 
Reprinted with permission from Cone, K.R., Kronenberg, Z.N., Yandell, M., and Elde, 
N.C. (2017). Emergence of a viral RNA polymerase variant during gene copy number 




Emergence of a Viral RNA Polymerase
Variant during Gene Copy Number
Amplification Promotes Rapid Evolution
of Vaccinia Virus
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ABSTRACT Viruses are under relentless selective pressure from host immune de-
fenses. To study how poxviruses adapt to innate immune detection pathways, we
performed serial vaccinia virus infections in primary human cells. Independent
courses of experimental evolution with a recombinant strain lacking E3L revealed
several high-frequency point mutations in conserved poxvirus genes, suggesting im-
portant roles for essential poxvirus proteins in innate immune subversion. Two dis-
tinct mutations were identified in the viral RNA polymerase gene A24R, which seem
to act through different mechanisms to increase virus replication. Specifically, a
Leu18Phe substitution encoded within A24R conferred fitness trade-offs, including
increased activation of the antiviral factor protein kinase R (PKR). Intriguingly, this
A24R variant underwent a drastic selective sweep during passaging, despite en-
hanced PKR activity. We showed that the sweep of this variant could be accelerated
by the presence of copy number variation (CNV) at the K3L locus, which in multiple
copies strongly reduced PKR activation. Therefore, adaptive cases of CNV can facili-
tate the accumulation of point mutations separate from the expanded locus. This
study reveals how rapid bouts of gene copy number amplification during accrual of
distant point mutations can potently facilitate poxvirus adaptation to host defenses.
IMPORTANCE Viruses can evolve quickly to defeat host immune functions. For pox-
viruses, little is known about how multiple adaptive mutations emerge in popula-
tions at the same time. In this study, we uncovered a means of vaccinia virus adap-
tation involving the accumulation of distinct genetic variants within a single
population. We identified adaptive point mutations in the viral RNA polymerase
gene A24R and, surprisingly, found that one of these mutations activates the nucleic
acid sensing factor PKR. We also found that gene copy number variation (CNV) can
provide dual benefits to evolving virus populations, including evidence that CNV fa-
cilitates the accumulation of a point mutation distant from the expanded locus. Our
data suggest that transient CNV can accelerate the fixation of mutations conferring
modest benefits, or even fitness trade-offs, and highlight how structural variation
might aid poxvirus adaptation through both direct and indirect actions.
KEYWORDS RNA polymerase, experimental evolution, genome analysis, innate
immunity, poxvirus, vaccinia virus
Although the mutation rates of animal viruses are much higher than those of theirhosts, the point mutation rate varies greatly between different types of viruses
(1–4). For example, some double-stranded DNA (dsDNA) viruses have point mutation
rates that are orders of magnitude lower than those of RNA viruses (3). Poxviruses, for
instance, are predicted to have relatively low point mutation rates due to 3=-5=
proofreading activity of the viral DNA polymerase (3, 5, 6). While recent estimates
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suggest a higher point mutation rate for poxviruses than for other dsDNA viruses (7, 8),
these rates are still lower than those for most RNA viruses. Observations that viruses
with various mutation rates flourish in shared hosts strongly predict that successful
adaptation of dsDNA viruses, including poxviruses, relies on mechanisms in addition to
the rapid sampling of point mutations.
Vaccinia virus (VACV) provides a useful model system for studying poxvirus evolu-
tion due to the vast repertoire of available molecular tools and numerous well-
characterized interactions between VACV-encoded factors and the host innate immune
system. One key interface involves interactions between VACV and the host nucleic acid
sensor protein kinase R (PKR). Upon binding viral dsRNA, PKR phosphorylates the
eukaryotic translation initiation factor eIF2!. Phosphorylation of eIF2! leads to a severe
block in protein translation and to attenuated viral replication. Like many poxviruses,
VACV encodes E3L and K3L, which inhibit PKR via different mechanisms (9–11).
Consistent with their role as key host range factors, VACV E3L and K3L vary in the
ability to block PKRs from different host species (9, 12). In particular, K3L is a poor
inhibitor of human PKR, such that a VACV strain lacking E3L (∆E3L) (13) exhibits a severe
replication defect during infection of HeLa cells (12). This deficiency places strong
selective pressure on the virus to adapt to counteract PKR. Previous courses of
experimental evolution of ∆E3L in HeLa cells revealed a recombination-based “genomic
accordion” mechanism, in which copy number variation (CNV) of the K3L gene allowed
rapid adaptation by inhibiting the activity of PKR (14). Although whole-genome se-
quencing of VACV revealed that each of the three replicate populations in this
experiment acquired an increased K3L copy number, there were differences between
populations in the recombination breakpoints as well as unique high-frequency point
mutations throughout the genome. These differences suggest that experimental evo-
lution is just beginning to uncover adaptive mutations and mechanisms contributing to
poxvirus evolution. Further analysis of evolving populations under different conditions
might reveal unrecognized means of virus adaptation.
In this study, we identified adaptive mutations in VACV genomes that arose during
serial infections of primary human fibroblast (HF) cells. Interestingly, two nonsynony-
mous point mutations, from independent replicate populations, were identified within
the A24R gene, which encodes a catalytic subunit of the viral RNA polymerase (vRNAP).
Experimental rescue analysis indicates that either a Leu18Phe or Lys452Asn amino acid
change in the A24R gene product is sufficient to provide a replication gain to the ∆E3L
virus in HF cells. Additionally, the A24R mutations we found seem to act through
mechanisms distinct from those of previously identified adaptive A24R mutations to
improve viral fitness. We also show that by blocking PKR activation, the K3L CNV arising
in our virus populations enhanced the accumulation of a point mutation in A24R. This
work provides a new view of how the rapid fixation of a beneficial point mutation, often
described as a selective sweep, can occur concurrently with recombination-mediated
adaptation in a viral population, and it illuminates a fundamental mechanism for how
structural variants (SVs) might enhance poxvirus adaptation.
RESULTS
Replication gains following serial infection of primary HF cells. To study mech-
anisms of viral adaptation, we performed serial VACV infections of primary human
fibroblast (HF) cells. ∆E3L replicates poorly in HeLa cells (12), so we first tested whether
the defect is similar for infection of primary human fibroblasts. While both ∆E3L and the
parental wild-type Copenhagen strain of VACV (VC-2) replicated equally in a permissive
hamster (BHK) cell line during 48-h infections, ∆E3L displayed an even stronger growth
defect compared to the growth of VC-2 in HF cells than in HeLa cells (Fig. 1A). This result
is consistent with cell type-specific innate immune responses to viral infection placing
different selective pressures on the virus (15), even between different human cell lines.
To test how VACV might adapt to primary human cells, we performed serial
infections of HF cells with ∆E3L in triplicate. Using viral titer as a measure of fitness, we
observed rapid gains in fitness over the course of 10 passages for all three replicate
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virus populations (Fig. 1B). Despite modest replication of the parental ∆E3L virus in HF
cells compared to HeLa cells, we observed comparable gains in replication of ∆E3L virus
populations over the course of our infections of HF cells (Fig. 1B) and HeLa cells, as
previously reported (14).
High-frequency point mutations in evolved virus populations. To define genetic
changes that might account for increases in viral fitness, we used deep sequencing of
viral genomes from each of the replicate populations after 10 rounds of serial infection
(P10). We obtained an average of !2,000" coverage across the genome for each P10
population. Excluding the inverted terminal repeat regions (1 to 5,000 bp and 186,737
to 191,737 bp), we identified nine single nucleotide polymorphisms (SNPs) not present
in the ∆E3L parent virus at a frequency of !1% for any P10 population, in addition to
20 shared differences compared to the VC-2 reference strain (Table 1). The nine SNPs
present in at least one of the three P10 populations but not in the ∆E3L parent virus
represent potentially adaptive mutations. All nine SNPs lie within open reading frames,
and notably, seven of them result in nonsynonymous amino acid changes or frame-
shifts (Fig. 2A). Remarkably, the highest-frequency SNP in each population caused a
substitution in an essential gene conserved among poxviruses, resulting in a Leu18Phe
amino acid substitution in A24R, encoding a catalytic subunit of the viral RNA poly-
merase (vRNAP) (16); a Glu495Gly amino acid substitution in E9L, encoding the viral
DNA polymerase (17, 18); and a Trp44Cys amino acid substitution in F10L, encoding a
kinase required for virion morphogenesis (19). These core genes are all involved in
replication and assembly, suggesting a common adaptive advantage through al-
tered replication cycle kinetics under nonoptimal conditions in which nucleic acid
sensors are activated. This may represent an indirect selection for altered replication
and assembly in addition to the direct influence of innate signaling pathways. Further-
more, another A24R mutation, resulting in a Lys452Asn amino acid substitution, was
identified in a replicate population independently of the Leu18Phe variant. This result
suggests that the A24R gene may be a common target for beneficial mutations in VACV,
consistent with previous reports of other adaptive A24R mutations (20–22). Together,
these high-frequency mutations suggest a common role for poxvirus genes encoding
essential viral functions in adaptation to activated host innate immune responses and
an altered cellular environment.
SVs in evolved virus populations. In addition to point mutations, genetic changes
in the form of gene copy number variation (CNV) have previously been shown to play
an adaptive role during poxvirus adaptation (14). To identify potentially adaptive
structural variants (SVs) in our evolved virus populations, we analyzed the P10 se-
quences by using the SV analysis implemented in the program Wham (23). We found








































FIG 1 Rapid adaptation of ∆E3L during experimental evolution in HF cells. (A) Cells were infected with
wild-type VC-2 or ∆E3L virus (MOI # 0.1) for 48 h. (B) Triplicate populations of ∆E3L virus were passaged
10 times in HF cells. Equal volumes of virus from every other passage were expanded in BHK cells for 48
h and titrated simultaneously. The similarly expanded parental ∆E3L virus titer is indicated by the dotted
line. All viral titers were measured in BHK cells by 48-h plaque assays performed in triplicate, and data
are mean PFU per milliliter $ standard deviations.
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breakpoints in the virus populations (Fig. 2B; Table 2). Sanger sequencing corroborated
each of these SVs to within one nucleotide of the putative breakpoint. The single SV
identified in the ∆E3L parent virus was also present in all three P10 populations
(breakpoint 7 in Table 2). This variant corresponds to the 11K vaccinia virus promoter
introduced during the deletion of E3L (13), resulting in two copies of this sequence,
found at different genomic locations (Fig. 2B). The remaining 6 SVs were present only
in the P10 virus populations, and each of them was associated with the K3L locus. There
was a corresponding increase in sequencing depth surrounding K3L for each P10 virus
population, but this was absent in the parent population (Fig. 2B). Three of the SNPs
from variant calling were located 1 bp from a structural variant breakpoint, and we
therefore categorized these as false-positive calls due to misaligned reads (Table 1). This
finding illustrates that SVs in poxvirus genomes should be considered when using
standard variant calling methods to identify SNPs.
A similar copy number amplification of the K3L locus was observed following serial
infections of HeLa cells with ∆E3L (14). In the previous study, we showed that CNV at
the K3L locus corresponds to an increased amount of K3L protein, which impairs PKR
activation. Interestingly, two of the seven breakpoints identified in this study were
identical to those observed in virus populations passaged in HeLa cells (14), suggesting
the presence of these variants at a level below the limit of detection in the ∆E3L parent
virus or indicating that these are preferential sites for recombination. These results,
combined with studies demonstrating CNV in other poxvirus genes in response to
selective pressure (24–26), continue to reveal CNV as a mechanism for rapid adaptation
of VACV.
TABLE 1 Point mutations in virus populations relative to the VC-2 reference sequence
Position ORFa
Nucleotide(s) Allele frequencyb
Reference Variant !E3L A P10 B P10 C P10
16033 A G 1.00 1.00 1.00 1.00
23443 C T 1.00 1.00 1.00 1.00
24256 G C 1.00 1.00 1.00 1.00
25525 G C 1.00 1.00 1.00 1.00
30295c K2L G A 0.00 0.14 0.00 0.02
30752 K4L GT G 0.00 0.00 0.00 0.11
35080 C G 0.85 0.69 0.67 0.63
35081 G C 0.86 0.80 0.78 0.75
40751 F10L C A 0.00 0.00 0.00 0.60
44312 A G 1.00 1.00 1.00 1.00
46730c T A 0.07 0.17 0.18 0.13
46742 C G 1.00 1.00 1.00 1.00
46743 G C 1.00 1.00 1.00 1.00
51482c A C 1.00 0.96 1.00 1.00
58304 E9L T C 0.00 0.00 0.80 0.00
69922 C T 0.09 0.06 0.08 0.04
77258 A T 1.00 1.00 1.00 1.00
81834 G A 1.00 1.00 1.00 1.00
85139 T C 1.00 1.00 1.00 1.00
95128 T C 0.32 0.38 0.37 0.40
104656 C T 1.00 1.00 1.00 1.00
120212 A7L G T 0.00 0.00 0.31 0.00
134369 A24R G T 0.00 0.91 0.00 0.00
135671 A24R G T 0.00 0.00 0.00 0.14
145840 T A 1.00 1.00 1.00 1.00
148905 A T 1.00 1.00 1.00 1.00
152700 G GC 1.00 1.00 1.00 1.00
172688 B13R G T 0.00 0.00 0.00 0.18
175621 B17L CT C 0.00 0.00 0.25 0.00
aThe ORF containing the mutation is shown for variant alleles (bold) not present in the ∆E3L parent virus
(also see Fig. 2A).
bAlleles with frequencies of !0.01 are shown.
cPredicted false-positive variant stemming from a misaligned read at a structural variant breakpoint (see
Table 2).
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A24R mutations increase viral fitness through distinct mechanisms. Following
10 passages in HF cells, each population of viruses harbored a unique set of mutations
that might contribute to increased fitness. The most drastic example was a Leu18Phe
amino acid substitution encoded within A24R that was nearly fixed (frequency ! 0.91)
in one virus population after 10 passages (Fig. 2A). The lack of other nonsynonymous
point mutations in this replicate population above a frequency of 1% strongly suggests
that this single mutation contributed to the observed increase in fitness (Fig. 1B). To
test this hypothesis, we generated a recombinant virus with this A24R mutation in the
parental ∆E3L strain (A24RLeu18Phe). Growth curve analysis with the permissive BHK cell
line revealed that the A24RLeu18Phe and ∆E3L viruses replicated to similar titers (Fig. 3A).
However, in HF cells, the A24RLeu18Phe virus exhibited a significant increase in titer
relative to that of ∆E3L from 48 to 72 h postinfection. Thus, the single nucleotide
change in A24R in the ∆E3L genetic background was sufficient to enhance viral fitness
under selective pressure in HF cells.
To examine how a single amino acid substitution encoded within A24R might













































FIG 2 Genetic changes in virus populations following experimental evolution. (A) Allele frequencies were
obtained by deep sequencing of viral genomic DNA from passage 10 virus populations compared to the ∆E3L
parent virus. Alleles with a frequency of!0.01 that were not present in the parent virus are shown. The VACV
open reading frame (ORF) and resulting amino acid change are listed at the top. FS, frameshift; Syn,
synonymous. *, the K2L allele is likely a miscalled structural variant. (B) Relative depths of coverage across the
viral genome are shown in black, excluding the inverted terminal repeat regions. Breakpoint positions of
structural variants called by Wham are shown as vertical lines, with 5= positions in red and 3= positions in
orange. The genomic locations of the K3L gene and the duplicated 11K promoter are indicated at the top.
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polymerases. Previous work used the crystal structure of Saccharomyces cerevisiae RNA
polymerase II to map A24R mutations encoding amino acid substitutions onto the
homologous subunit in yeast, RBP2 (22). RBP2 is the second largest subunit of yeast
RNA polymerase II and forms an active site of the enzyme with RBP1 (27). Using a similar
approach, we generated an amino acid alignment between the VACV A24R gene
product and S. cerevisiae RBP2 to predict the locations of amino acid substitutions
encoded within A24R mutants on the S. cerevisiae RNA polymerase II crystal structure
(PDB entry 1I50) (28). This analysis suggested that the Leu18Phe substitution encoded
by the corresponding A24R mutant is located on a solvent-exposed surface of the
polymerase distal from the active site of the enzyme (Fig. 3B). This surface might be
involved in binding other factors to the polymerase, such that a Leu18Phe substitution
may alter a protein-protein interaction(s). However, little is currently known about viral
or host proteins that bind to the A24R gene product, making it difficult to predict the
functional consequences of this mutation.
Distinct adaptive mutations in A24R demonstrate how vRNAP variation can affect
viral fitness. Two A24R mutations were shown to influence transcription elongation,
resulting in the production of short virus transcripts in response to isatin-!-
thiosemicarbazone (IBT) selection (21, 22). IBT-resistant mutations have also been
shown to reduce the activation of the host dsRNA sensor oligoadenylate synthetase
(OAS) (29, 30). These studies suggest that changes to transcript length, dictated by
vRNAP, can influence the activation of innate immune dsRNA sensors in the cell.
Indeed, another A24R mutation was recently identified that reduces the activation of
the dsRNA sensor PKR (20). Without E3L, viruses are more vulnerable to PKR and OAS
activities, and thus we hypothesized that the A24R substitutions we identified might act
through a similar mechanism to reduce the activation of dsRNA sensors.
To test whether either of the A24R variants from our evolved virus populations is
sufficient to alter innate immune responses, we first determined whether dsRNA
production was affected by the vRNAP variants. A dot blot of dsRNAs from infected cells
revealed less total dsRNA in cells infected with either the A24RLeu18Phe or A24RLys452Asn
recombinant virus than that in cells infected with the ∆E3L virus (Fig. 3C). Viruses with
the Leu18Phe substitution produced a notable reduction in dsRNA, which might reflect
changes to transcript length or stability, or even changes to a subset of transcripts.
Additionally, the overall reduction in dsRNA might have affected the activation of
dsRNA sensors and contributed to the fitness increases observed for viruses harboring
the A24R variants.
To test whether a reduction in dsRNA affects downstream nucleic acid sensing
pathways, we measured the activities of the OAS/RNase L and PKR pathways in cells
infected with recombinant viruses harboring the A24R mutant-encoded Leu18Phe or
Lys452Asn substitution. We did not detect any notable difference in RNase L activity as
judged by rRNA degradation following infection with either the A24RLeu18Phe or
A24RLys452Asn recombinant virus (Fig. 3D). This result suggests that the OAS/RNase L
pathway was not significantly affected by these A24R substitutions, despite the reduc-
tion in dsRNA. We next tested whether either of the A24R variants reduced PKR
TABLE 2 Structural variants in virus populations relative to the VC-2 reference sequence
Breakpoint
Genomic
positiona Read support (no. of reads [5=, 3=])
5= 3= !E3L A P10 B P10 C P10
1 26302 35775 0, 0 0, 0 0, 0 112, 102
2 27105 32160 0, 0 0, 0 74, 70 0, 0
3 27322 33524 0, 0 0, 0 0, 0 105, 73
4 28875 33568 0, 0 0, 0 114, 74 0, 0
5 30287 30840 0, 0 0, 0 164, 125 0, 0
6 30296 31725 0, 0 190, 137 0, 0 96, 85
7 46731 51483 179, 260 159, 465 179, 472 200, 389
aPositions supported by !10 reads are shown.
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activation as measured by changes in phosphorylated PKR and phosphorylated eIF2!
protein levels in infected HF cells. Counter to our expectation, immunoblot analysis
indicated that HF cells infected with the A24RLeu18Phe virus repeatedly showed in-
creased levels of both phosphorylated PKR and eIF2! (Fig. 3E). While the A24RLeu18Phe
virus conferred a replication benefit at late time points that may account for an increase
in PKR activation, this is unlikely given the equivalent viral titers between the
A24RLeu18Phe and ∆E3L viruses at the 6-h time point (Fig. 3A) when we harvested total
protein. In contrast, there were no substantial changes in PKR activation upon infection
with the A24RLys452Asn virus compared to infection with ∆E3L. These data suggest that
the A24R variants we identified work through mechanisms distinct from those for other
























































































































FIG 3 A24R mutations increase fitness through distinct mechanisms. (A) Single-step growth curve
analysis (MOI ! 5.0) was performed in triplicate with either the ∆E3L or A24RLeu18Phe recombinant virus
in BHK or HF cells. Viral titers were measured in BHK cells by a 72-h plaque assay, and data are mean PFU
per milliliter" standard deviations. ***, P# 0.005 relative to ∆E3L within each cell type, by 2-way analysis
of variance (ANOVA) followed by Bonferroni’s multiple-comparison test. (B) Positions of A24R mutations
identified in this study (red spheres) and previously published data (yellow spheres) were mapped onto
the homologous S. cerevisiae RNAP II structure (PDB entry 1I50). The RBP2 protein (homologous to the
A24R gene product) is shown as blue ribbons in the context of the multisubunit polymerase shown in
gray (the active site is shown in green). (C) dsRNA dot blot with decreasing amounts of total RNA from
HF cells left untreated (mock) or infected with the ∆E3L, A24RLeu18Phe, or A24RLys452Asn virus (MOI ! 10.0)
for 13 h. An image representative of three independent blots is shown. (D) rRNA degradation in HF cells
left untreated (mock), transfected with poly(I·C), or infected with the ∆E3L, A24RLeu18Phe, or A24RLys452Asn
virus (MOI ! 5.0) for 6 h. Filled arrowheads indicate 28S and 18S rRNAs, and open arrowheads indicate
degradation products. (E) Immunoblot of phosphorylated or total PKR and phosphorylated or total eIF2!
in HF cells infected with the ∆E3L, A24RLeu18Phe, A24RLys452Asn, or replicate A passage 10 virus (MOI! 5.0)
for 6 h. An image representative of five independent blots is shown.
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activation with the A24RLeu18Phe virus was paradoxical, considering the reduction in
dsRNA and the replication advantage we observed in HF cells.
The A24R Leu18Phe variant confers fitness trade-offs. Given that E3L and K3L act
as host range factors, blocking innate immune activation in some hosts but not others
(12), we tested the impact of A24R variation during infections of cells from other
primate species. We performed triplicate 48-h infections in two human and two Old
World primate cell lines: HF cells, HeLa cells, rhesus macaque fibroblasts, and African
green monkey fibroblasts. In each of the four cell lines tested, the parental ∆E3L virus
exhibited considerably reduced replication compared to that in a permissive BHK cell
line (Fig. 4A). The A24RLys452Asn virus replicated equally to or better than ∆E3L in all
primate cells tested, suggesting that the fitness increase provided by the A24R
Lys452Asn variant is not species or cell type specific. In contrast, while A24RLeu18Phe
virus replication showed a 43-fold increase in HF cells relative to replication of the
∆E3L virus, titers were significantly reduced in HeLa cells and African green monkey
fibroblasts. The clear differences in A24RLeu18Phe viral titers between cells from two
Old World monkey species and also between two human cell lines reveal a potential
fitness trade-off for viruses harboring this substitution.
Consistent with a fitness trade-off in some cell types, the A24RLeu18Phe virus dis-
played a small-plaque phenotype in permissive BHK cells (Fig. 4B). This phenotype is
associated with defects in cell-to-cell spread (31–33), although the A24RLeu18Phe virus
produced approximately the same number of infectious particles as ∆E3L in BHK cells
(Fig. 3A). The small-plaque phenotype in conjunction with differential replication
among cell lines supports the idea that the A24R Leu18Phe variant is beneficial only
under certain conditions. Furthermore, the growth benefit in HF cells and the growth
defect in HeLa cells highlight that specific, species-independent differences between
the cell lines can contribute to the success or failure of the A24RLeu18Phe virus.
Accelerated sweep of the A24R Leu18Phe variant during adaptive gene copy
number amplification. The A24R Leu18Phe variant rose to near fixation in a viral
population during experimental evolution of ∆E3L in HF cells (Fig. 2; Table 1). The rapid
dominance of the variant in this population was unusual given the slower accumulation
dynamics of mutations within other replicate populations. For example, the A24R
Lys452Asn variant provided a similar replication increase alone (Fig. 4A) yet reached a
frequency of only 14%, in contrast to the 91% frequency of the A24R Leu18Phe variant











































FIG 4 The A24R Leu18Phe variant confers fitness trade-offs. (A) Cell lines were infected in triplicate with
the ∆E3L, A24RLeu18Phe, or A24RLys452Asn virus (MOI ! 0.1) for 48 h. Viral titers were measured in BHK cells
by a 72-h plaque assay, and data are mean PFU per milliliter " standard deviations. *, P # 0.05; **, P #
0.01; ***, P # 0.005 relative to ∆E3L within each cell type, by one-way ANOVA followed by Dunnett’s
multiple-comparison test. Rh, rhesus macaque fibroblasts; AGM, African green monkey fibroblasts. (B)
Average plaque size " standard deviation for three independent wells of BHK cells infected with the
∆E3L or A24RLeu18Phe virus (MOI ! 0.1) for 48 h. A representative image is shown. ***, P # 0.005 by
2-tailed t test.
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induced by the A24R Leu18Phe variant (Fig. 3E) would prevent the mutation from
reaching fixation so rapidly. To more carefully determine how this mutation arose, we
analyzed earlier passages during the course of experimental evolution. Remarkably, the
A24R Leu18Phe variant was detectable only starting at passage 8 as judged by
sequencing of A24R amplicons in each passage, prompting us to deep sequence virus
populations from passages 7 to 9. Genome sequence analysis revealed that the
mutation rapidly increased in frequency with each successive passage late in the
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FIG 5 Copy number variation enhances the sweep of a point mutation. (A) Allele frequencies of !0.01 for
replicates A and C were obtained by deep sequencing of P7 to P10 virus populations, and positions in ORFs
and resulting amino acid changes are listed at the top, as in Fig. 2A. FS, frameshift; Syn, synonymous. (B)
Genome structures from direct sequencing across the CNV breakpoints identified by Wham (Table 2) for
replicate A and C passage 10 populations. (C) Southern blotting using a K3L-specific probe was performed on
digested viral DNAs from the indicated viral populations. Sizes (left) and numbers of K3L copies (right) are
shown. (D) Viruses were mixed as listed, at a ratio of 1:100, and passaged twice for 48 h in HF cells (MOI " 0.1).
Titers were measured in BHK cells by 72-h plaque assays performed in triplicate, and data are mean PFU per
milliliter # standard deviations. A24R Leu18Phe variant abundances are listed below the graph, as input (P0)
or as measured by deep sequencing (P1 and P2).
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present at frequencies above 1% in passages 7 to 10 (replicate A), which is in stark
contrast to the findings for replicate C, in which multiple mutations across the genome
fluctuated in frequency from passages 7 to 10 (Fig. 5A). The rapid accumulation of the
A24R Leu18Phe variant, as well as a lack of any other mutations across the genome, is
consistent with a strong selective sweep of the mutation in the replicate A population.
However, because the A24RLeu18Phe virus also increased PKR activation, the question
remained as to how the mutation induces increased virus replication.
The increased copy number of the K3L gene in the P10 population provided a clue
to how the A24R mutation might rapidly sweep to fixation despite increasing PKR
activation. There was only one recombination breakpoint at P10 for replicate A, as
opposed to multiple breakpoints for replicates B and C (Fig. 5B; Table 2). This suggests
that when the selective sweep of the A24R Leu18Phe variant occurred, these viruses
also contained a single K3L CNV breakpoint. To determine whether the K3L gene copy
number amplification or the A24R Leu18Phe mutation arose first in the virus popula-
tion, we used Southern blot analysis to measure K3L CNV during experimental evolu-
tion of replicate A. We first detected K3L CNV at passage 4, and the proportion of
viruses with the population harboring CNV seemed to remain steady through passage
10, as indicated by the consistent intensities of bands within each lane (Fig. 5C). Since
the A24R Leu18Phe substitution did not emerge until passage 7, the earlier appearance
of K3L CNV might have preemptively blocked PKR activation that would otherwise be
induced by the A24R Leu18Phe variant, facilitating its rapid fixation. Indeed, in cells
infected with the replicate A P10 virus, which contained both the A24R Leu18Phe
substitution and K3L CNV, there was a marked reduction in PKR activation (Fig. 3E). This
result suggests that K3L CNV can compensate for the activation of PKR induced by the
A24R Leu18Phe variant.
To test whether rapid accumulation of the A24R Leu18Phe variant was influenced by
the K3L copy number, we wanted to track increases of the A24R Leu18Phe variant in
virus populations with and without K3L CNV. To do this, we infected cells with viruses
containing the A24R Leu18Phe substitution alone (A24RLeu18Phe), K3L CNV alone (CNV),
or the combination of the two genetic changes (A24RLeu18Phe!CNV), each starting at a
ratio of 1:100 with the parental ∆E3L virus (see Materials and Methods for strain details).
Compared to ∆E3L alone after two passages in HF cells, the A24RLeu18Phe:∆E3L virus
population replicated "10-fold better, CNV:∆E3L "1,000-fold better, and A24RLeu18Phe:
CNV:∆E3L "10,000-fold better (Fig. 5D). These data suggest that while either the A24R
Leu18Phe variant or K3L CNV is sufficient for a fitness benefit in HF cells, the combi-
nation is additive and may therefore facilitate fixation of the A24R Leu18Phe variant. We
next analyzed the abundance of the A24R Leu18Phe substitution in the virus popula-
tions to determine if it accumulated faster in the presence of K3L CNV. Starting at 1%
of the population, the mutation reached 98.8% abundance after only two passages
when multiple copies of K3L were present, compared to 45.2% abundance at passage
2 with a single copy of K3L (Fig. 5D). The increased accumulation of the variant in the
presence of CNV is consistent with the added fitness benefit for viruses carrying both
genetic changes. Thus, the A24R Leu18Phe substitution accumulated markedly faster in
the presence of K3L CNV, which suggests that the reduction in PKR activation provided
by increased K3L expression may have facilitated the rapid rise of the distant A24R
mutation.
DISCUSSION
In this study, we found a new means of poxvirus adaptation to innate immune
response pathways. Vaccinia virus has proven to be a useful model for experimental
evolution and continues to reveal the genetic basis of various poxvirus adaptations (14,
20, 25). We charted the rise of multiple point mutations over the course of 10 serial
infections, which is consistent with adaptive evolution through several independent
mechanisms. Most notable among these was the rapid accumulation of a Leu18Phe
substitution resulting from a mutation within A24R, which encodes a subunit of the
viral RNA polymerase. Unlike in other evolved virus populations, the rise of the A24R
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Leu18Phe variant appeared in the near absence of other point mutations (Fig. 5A), an
observation reminiscent of clonal interference, where strongly adaptive point muta-
tions on separate genomes can compete and transiently dominate within asexual
populations (34, 35). However, a case of clonal interference seemed unlikely given the
high rates of recombination in poxviruses (36–39) and the modest replicative advan-
tage we measured in a recombinant strain containing only the A24R Leu18Phe muta-
tion (Fig. 3A). We therefore considered the impact of K3L gene copy number amplifi-
cation as a facilitating event for the rapid accumulation of the A24R Leu18Phe variant
during this course of experimental evolution.
We previously found that genomes harboring multiple copies of K3L produced more
protein product, which resulted in fitness gains for viruses under selective pressure to
overcome the antiviral factor PKR (14). In two populations evolved in HeLa cells, we
observed the additional emergence of a beneficial point mutation in K3L during serial
infections, which we predict is more likely to occur in viruses with multiple copies of the
gene (14). However, as we did not observe K3L mutations in every evolved population,
adaptive mutations likely still arise at a low frequency. In this study, we observed a
beneficial point mutation in a gene distant from the expanded K3L locus (!100,000 bp
apart) that may benefit from the presence of virus genomes harboring multiple copies
of K3L. We speculate that the Leu18Phe substitution encoded within the A24R variant
alters virus transcription to promote virus replication and found that while the vRNAP
variant does reduce total dsRNA, it also activates PKR (Fig. 3C and E). These results show
that the A24RLeu18Phe virus produces less dsRNA and suggest a complicated mechanism
in which the polymerase variant alters RNA production in a way that activates PKR
despite the reduction in dsRNA. Further analysis of viral transcripts may reveal changes
to transcript length or other modifications to specific transcripts that modulate immune
sensing.
Despite providing modest fitness gains and activating PKR, the A24R Leu18Phe
mutation can rapidly sweep to fixation in virus populations in the presence of multiple
copies of K3L that block PKR activation. Consistent with this idea, we observed rapid
fixation of the A24R Leu18Phe variant following K3L copy number amplification (Fig. 5A
and C) and a 2-fold increase in the accumulation of the A24R Leu18Phe variant in the
presence of multiple K3L copies compared to that in populations with a single copy of
K3L (Fig. 5D). These data suggest that adaptive copy number variation can facilitate
the rapid accumulation of otherwise modestly beneficial mutations, such as the A24R
Leu18Phe variant. In this way, recombination-based CNV may enhance the viability of
an expanded set of beneficial mutations that otherwise suffer from trade-offs (e.g.,
activation of PKR) and might otherwise be unable to sweep through populations. Given
that copy number amplification events are likely to be transient (14), this foothold may
be temporary, as suggested by previous work describing the accumulation of beneficial
point mutations causing the collapse of CNV (20). In the current study, CNV of the K3L
locus persisted through passage 10 (Fig. 5C), but it might collapse to a single copy after
further rounds of infection. In any case, copy number variation provides an opportunity
for mutations to sweep rapidly through genes both undergoing CNV and distant from
CNV, despite small initial fitness gains relative to those for other mutations in the
population. Given long periods of evolutionary time, the presence of seemingly simple,
beneficial point mutations in virus populations may belie a more volatile history of
fixation involving the aid of adaptive yet transient gene copy number amplification
events.
MATERIALS AND METHODS
Cells and viruses. Primary human fibroblast (HF) cells derived from human foreskin were a gift from
Adam Geballe (Fred Hutchinson Cancer Research Center). HF, HeLa, and BHK cells were maintained in
Dulbecco’s modified Eagle’s medium (DMEM; HyClone) supplemented with 10% fetal bovine serum
(HyClone), 1% penicillin-streptomycin (GE Lifesciences), and 1% stable L-glutamine (GE Lifesciences).
Rhesus fibroblasts (from Macaca mulatta; Coriell Institute for Medical Research) and African green
monkey fibroblasts (from Cercopithecus aethiops; Coriell Institute for Medical Research) were maintained
in minimum essential medium, alpha modification (MEM-alpha; HyClone), supplemented as described
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above for DMEM. The Copenhagen strain of vaccinia virus (VC-2) and the E3L deletion virus (∆E3L) (13)
were generous gifts from Bertram Jacobs (Arizona State University).
Experimental evolution. For each infection during experimental evolution, 150-mm dishes were
seeded with an aliquot from the same stock of HF cells (5 ! 106 cells/dish). Triplicate dishes of cells were
infected (multiplicity of infection [MOI]" 1.0 for P1 and 0.1 for subsequent passages) from a single stock
of ∆E3L virus for 2 h in a minimal volume and then supplemented with medium. At 48 h, cells were
collected, washed, pelleted, and resuspended in 1 ml of medium. Virus was released by one freeze-thaw
cycle followed by sonication. Viral titers were determined by a 48-h plaque assay with BHK cells between
passages. Following 10 passages, equal volumes of virus from every other passage were expanded in BHK
cells for 48 h, with viral titers determined by a 48-h plaque assay with BHK cells, or for 72 h for replicate
A passage 10 due to a small-plaque phenotype. An equal volume from the input parental ∆E3L virus
stock was similarly expanded for comparison.
VACV whole-genome deep sequencing. Total viral genomic DNA was collected following a 24-h
infection of BHK cells (MOI" 0.1) as previously described (41). Libraries were constructed using a Nextera
XT DNA sample prep kit (Illumina, Inc.). Barcoded libraries were combined and sequenced using an
Illumina MiSeq instrument at the High-Throughput Genomics Core (University of Utah). Reads were
mapped to the VC-2 reference genome (accession number M35027.1; modified on http://poxvirus.org)
(42) by using BWA mem (v0.7.10) (40) in default mode. PCR duplicates were removed, and the read depth
was calculated using samtools (v0.1.18) (43). We utilized the Genome Analysis Toolkit (v3.2-2) (44) for
base quality score recalibration, indel realignment, and variant calling across all samples (45, 46). We
utilized Wham (v1.7.0-272-g078c-dirty) for structural variant calling (23). SNP and depth plots were
generated in R (https://www.r-project.org/).
Recombinant virus generation. A sequence of 500 bp of homology surrounding the Leu18Phe-
encoding mutation in A24R was amplified by PCR from replicate A passage 10 viral DNA by using primers
A24R_1F (5=-CCTCCTCTCGAGCCCTCTCTGTTAGATGAGGATAGC) and A24R_1R (5=-CCTCCTACTAGTCAGTG
AACGTGGCTAATGCG). A sequence of 500 bp of homology surrounding the Lys452Asn-encoding muta-
tion in A24R was amplified by PCR from VC-2 viral DNA by using primers A24R_2F (5=-CCTCCTCTCGAG
CGTTGGCACATGATGAATTAGAGAATTAC) and A24R_2R (5=-CCTCCTACTAGTGAGATGCGACTAGAGCATTTT
CTATAGTG). The resulting PCR products were digested with XhoI and SpeI (New England BioLabs), gel
purified, and cloned into pEQ1422 (a gift from A. Geballe, Fred Hutchinson Cancer Research Center) (20)
cut with the same enzymes to generate pEQ1422-Leu18Phe and pEQ1422-A24R_2. The Lys452
Asn-encoding mutation was introduced into pEQ1422-A24R_2 by use of site-directed mutagenesis
primers A24R_Lys452Asn_F (5=-GTTGGATTTTATCCGGATCAAGTAAATATTTCAAAGATGTTTTCTGTCA) and
A24R_Lys452Asn_R (5=-TGACAGAAAACATCTTTGAAATATTTACTTGATCCGGATAAAATCCAAC) (pEQ1422-
Lys452Asn).
BHK cells were infected with ∆E3L (MOI " 1.0) and then transfected at 1 h postinfection with
pEQ1422-Leu18Phe or pEQ1422-Lys452Asn by use of FuGENE6 (Promega) according to the manufactur-
er’s protocol. Infected cells were collected at 48 h postinfection, and viruses were released by one
freeze-thaw cycle followed by sonication. Resulting viruses were selected using transient dominant
selection (47). Briefly, viruses were plaque purified three times in the presence of 600 !g/ml hygromycin
B (Sigma-Aldrich), followed by three rounds of plaque purification without hygromycin B. The presence
of the Leu18Phe or Lys452Asn substitution and loss of the Hygr phenotype were confirmed by PCR
followed by Sanger sequencing. Viruses were amplified and titers measured in BHK cells.
One-step growth curve. BHK or HF cells were infected with VACV ∆E3L or A24RLeu18Phe (MOI " 5.0)
in triplicate, and the virus was replaced with fresh medium after 2 h. Cells were harvested at 2, 6, 12, 24,
48, and 72 h postinfection, and viral titers were determined by a 72-h plaque assay with BHK cells.
Modeling. Amino acid alignment between the VACV A24R gene product and S. cerevisiae RBP2 was
generated using Clustal Omega (v1.2.1). Corresponding A24R variant residues were then mapped onto
the S. cerevisiae RNAP II crystal structure (PDB entry 1I50) (28) by use of Chimera software (48;
http://www.cgl.ucsf.edu/chimera/).
dsRNA dot blotting. HF cells were left untreated (mock) or infected with the ∆E3L, A24RLeu18Phe, or
A24RLys452Asn virus (MOI " 10) for 13 h. Total RNA was collected from infected cells, and dilutions were
spotted onto nylon membranes (GE Lifesciences). Membranes were allowed to dry before two rounds of
UV cross-linking. Blots were blocked for 1 h in phosphate-buffered saline with Tween (PBST) plus 5% milk
and then incubated with M"dsRNA J2 (1:1,000; Scicons) for 1 h followed by G"M-IgG-HRP (1:50,000;
Millipore) for 1 h. Blots were then activated with WesternBright ECL reagent (Advansta) and exposed to
autoradiography film (GeneMate), which was developed in a Mini-Med 90 film processor (AFP Imaging).
rRNA degradation assay. HF cells were pretreated with interferon alpha for 24 h. Cells were then
left untreated (mock), transfected with poly(I·C), or infected with the ∆E3L, A24RLeu18Phe, or A24RLys452Asn
virus (MOI" 5.0) for 6 h. Total RNA was harvested, and a total of 225 ng/lane was run on an Agilent 2200
TapeStation instrument.
Immunoblot analysis. HF cells were left untreated (mock) or infected with the ∆E3L, A24RLeu18Phe,
A24RLys452Asn, or replicate A P10 virus (MOI " 5.0) for 6 h. Protein lysates were collected in RIPA lysis
buffer, and total protein concentrations were quantified by Bradford assay by use of a Synergy HT plate
reader (BioTek). Equivalent amounts of lysate were separated in a precast Mini-Protean TGX gel (Bio-Rad)
and transferred to a polyvinylidene difluoride (PVDF) membrane (Immobilon). Blots were blocked for 30
min in PBST plus 5% milk, or for 10 min followed by three washes for phospho-specific antibodies. Blots
were then incubated with the following primary antibodies overnight at 4°C: M"PKR B-10 (1:200; Santa
Cruz), R"Phospho-PKR E120 (1:500; Abcam), R"eIF2" (1:1,000; Cell Signaling), and M"Phospho-eIF2"
(1:250; Cell Signaling). Blots were probed with the appropriate secondary antibody for 1 h at room
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temperature, i.e., G!M-IgG-HRP (1:50,000; Millipore) or G!R-IgG-HRP (1:50,000; Millipore), activated with
WesternBright ECL reagent (Advansta), and exposed to autoradiography film (GeneMate), which was
developed in a Mini-Med 90 film processor (AFP Imaging).
Plaque size analysis. BHK cells were infected with the ∆E3L or A24RLeu18Phe virus (MOI ! 0.1) for 48
h and then stained with crystal violet. Plates were imaged on a Gel Doc XR" system (Bio-Rad), and
plaque size was quantified using ImageJ v1.48 software (Rasband). Three independent wells, for a total
of 350 plaques, were analyzed for each virus.
Southern blot analysis. Total viral DNA was collected as described above, and #2 "g per sample
was digested with BspEI (New England BioLabs). Digested DNAs were separated by agarose gel
electrophoresis and transferred to nylon membranes (GE Lifesciences) by vacuum transfer, followed by
UV cross-linking. The resulting blots were probed with PCR-amplified K3L by use of a DIG High-Prime
DNA Labeling & Detection starter kit II (Roche) according to the manufacturer’s protocol.
Mutation accumulation assay. The replicate A P10 virus was passaged an additional three times in
HF cells until the A24R Leu18Phe variant was fixed (A24RLeu18Phe"CNV virus). The K3L CNV-only virus
contains the same CNV breakpoint but has no mutations in A24R (CNV virus). BHK cells were infected
with viruses mixed at a ratio of 1:100, i.e., A24RLeu18Phe:∆E3L, CNV:∆E3L, or A24RLeu18Phe"CNV:∆E3L, for
two passages in BHK cells (MOI ! 0.1). All passages were collected after 48 h as described above and
titrated by a 72-h plaque assay with BHK cells.
Accession number(s). All deep-sequencing data are available at the Sequence Read Archive under
accession number SRP073123.
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Kelsey R. Cone*1, Thomas A. Sasani*1,2, Aaron R. Quinlan1,2, and Nels C. Elde1 
 
Abstract 
Gene copy number variation promotes rapid adaptation of poxviruses. These gene 
amplification events can also involve the emergence of beneficial single nucleotide 
variants that accumulate in dynamic gene arrays. Tracking the dynamics of variant 
fixation in heterogeneous virus populations is a difficult task, especially when relying 
solely on short read sequencing technologies. We developed methods using Oxford 
Nanopore long read sequencing to perform high resolution analyses of single nucleotide 
variation within a poxvirus host range gene undergoing copy number amplification 
during courses of experimental evolution. These methods allowed us to phase a beneficial 
point mutation generating a His47Arg variant within expanding K3L gene arrays in 
individual viral genomes sampled from the population. Our results reveal concerted 
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evolution of the K3LHis47Arg variant, in which virus genomes harboring multiple K3L 
copies rapidly homogenized the beneficial mutation. These intriguing observations of 
poxvirus adaptation through concerted evolution reveal a new facet of virus evolution 
reminiscent of other organisms containing large repetitive genomic regions. 
 
Introduction 
Viruses can undergo rapid adaptation, given large population sizes and short 
replication cycles facilitating the accumulation of beneficial variants. For RNA viruses, 
high point mutation rates generate diverse populations from which advantageous variants 
quickly emerge under selection (Duffy et al., 2008; Holland et al., 1982; Sanjuán et al., 
2010). Studies tracking RNA viruses revealed the simultaneous accumulation of 
mutations in a population, described as quasi-species, that reflect the success of highly 
heterogeneous virus populations (reviewed in Andino and Domingo, 2015; Domingo et 
al., 2012). Many DNA viruses contain larger genomes and lower point mutation rates 
(Gago et al., 2009; Sanjuán et al., 2010), which makes tracking variants at a population 
level more difficult. As such, less is known about the genetic diversity maintained in 
populations of DNA viruses. 
The DNA virus family Poxviridae presents a useful system for examining 
population dynamics of variant accumulation because of high recombination rates that 
may allow for advantageous mutations to emerge simultaneously within individual 
genomes (Ball, 1987; Evans et al., 1988; Merchlinsky, 1989; Spyropoulos et al., 1988). 
Poxvirus DNA polymerase genes encode both replicase and recombinase activities, 
reflecting a tight coupling of these essential functions for virus replication (Colinas et al., 
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1990; Hamilton and Evans, 2005; Willer et al., 1999). Abundant recombination may also 
reduce the impact of clonal interference between genomes (Kim, 2005; McDonald et al., 
2016), and could facilitate the spread of rare variants between co-infecting viruses (Xiao 
et al., 2016). Poxvirus recombination also influences structural variation within genomes, 
which can result in rapid gene copy number amplification events (Brennan et al., 2014; 
Cone et al., 2017; Elde et al., 2012). Copy number variation (CNV) is also proposed to 
provide a genetic foothold in otherwise unfavorable conditions to allow greater sampling 
of potentially beneficial mutations (Brennan et al., 2014) distributed both within and 
outside of genomic regions undergoing CNV (Cone et al., 2017). Moreover, the presence 
of gene copy arrays predicts the increased probability of a beneficial point mutation 
arising in the expanded locus. Consistent with this idea, we discovered an advantageous 
single nucleotide variant (SNV) within amplified K3L gene arrays in populations of 
vaccinia virus during courses of serial infection (Elde et al., 2012). Although the 
beneficial point mutation, resulting in a His47Arg amino acid change (K3LHis47Arg), 
emerged in multiple replicate populations, the fate of the variant within virus genomes 
harboring copy number amplification of K3L is unclear. 
The emergence of a single nucleotide variant within a gene undergoing copy 
number variation in an evolving poxvirus population provides a unique system to explore 
variant dynamics in the context of recombination and gene amplification events. It has 
long been postulated that gene duplications are an important source for creating genetic 
novelty (Nei, 1969; Ohno, 1970; Stephens, 1951), and studies in eukaryotic and bacterial 
systems have revealed some of the ways gene duplications promote evolution (reviewed 
in Magadum et al., 2013). Whether similar patterns exist in viral genome evolution is 
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unknown. In this study, analyses of variant dynamics during gene copy number 
amplifications in poxvirus populations reveal new insights into adaptive mechanisms 
driving poxvirus genome evolution. We developed methods to apply Oxford Nanopore 
long read sequencing to discover the precise location of the K3LHis47Arg single nucleotide 
variant within K3L gene arrays. The ability to phase variants within individual virus 
genomes containing multiple K3L gene copies revealed patterns of variant accumulation 
similar to those found in other organisms such as bacteria and yeast. These observations 




Accumulation of a single nucleotide variant within gene copy 
number expansions 
To explore variant dynamics in a virus population following gene amplification, 
we studied a vaccinia virus (VACV) population in which gene copy number variation 
preceded the appearance of a beneficial point mutation in that gene. Adaptive CNV of the 
VACV K3L gene was detected after four serial passages under selection in HeLa cells, 
and overall gene copy number appeared fairly constant by passage ten (P10) (Elde et al., 
2012). The SNV generating the K3LHis47Arg variant was first detected at P5, and reached a 
population allele frequency of about 12% by P10, suggesting that the variant confers a 
small fitness benefit (Elde et al., 2012). Consistent with this idea, the K3LHis47Arg variant 
was previously shown to more potently inhibit human PKR (Kawagishi-Kobayashi et al., 
1997). To determine whether the K3LHis47Arg variant would continue to increase in 
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abundance under selection, we performed an additional ten passages in triplicate in HeLa 
cells starting with the P10 virus population. All three replicate populations showed 
additional fitness gains through P14, at which point viral titers reached a plateau that 
continued through P20 (Figure 4.1). These results suggest all virus populations reached a 
maximum replication ability under these selective conditions.  
We analyzed viral genomes from each P20 population by deep sequencing on an 
Illumina MiSeq instrument to assess genetic changes underlying adaptation, and found 
that the K3LHis47Arg variant had increased in frequency to near fixation in all three 
replicate populations (frequency = 0.86-0.91, Figure 4.1). Further analysis of the replicate 
A population revealed that the K3LHis47Arg variant reached an intermediate frequency at 
P15 (frequency = 0.58, Figure 4.1), consistent with a steady accumulation of the 
K3LHis47Arg variant over time. We next assessed the same replicate A virus populations 
for the presence of K3L CNV to determine whether there were population-level changes 
in K3L copy number. Southern blot analyses of passages 10, 15, and 20 revealed a 
similar proportion of viruses harboring multiple copies of K3L throughout these passages 
(Figure 4.1). Thus, we did not observe any changes to overall K3L CNV, consistent with 
a constant selective pressure maintaining multiple K3L copies within the population. 
These data show that the K3LHis47Arg variant continued to increase in frequency from P10 
to P20, while overall gene copy number distribution remained constant. 
 
Identification of single-copy and multicopy K3L sequencing reads 
We utilized an in-depth analysis of viral genomes containing different K3L copy 
number to determine the dynamics by which the K3LHis47Arg variant accumulated within 
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expanded gene arrays. The two structural variant breakpoints identified in the P10 
population generating tandem K3L arrays (Elde et al., 2012) each create a repetitive unit 
over 500bp in length (Figure 4.2). Thus, our initial 150bp paired-end Illumina MiSeq 
sequencing reads were of insufficient length to definitively determine whether the 
K3LHis47Arg variant is present in multicopy genomes (Figure 4.2). To identify single 
nucleotide variants within genomes containing multiple K3L copies, we utilized long 
reads generated on the ONT MinION platform. The MinION sequencing platform is 
capable of reliably generating 6-8kbp reads, and is reported to produce reads in excess of 
150kbp (Ip et al., 2015; Jain et al., 2016). Thus, a single read capable of spanning 
multiple K3L copies permits variant calling in a multicopy genome, which has not 
previously been feasible for these large DNA viruses using current Illumina sequencing 
technologies (Figure 4.2). 
In our studies, long sequencing reads allowed us to phase the K3LHis47Arg variant 
to single viral genomes in the context of K3L CNV. We performed multiple independent 
MinION sequencing reactions with viral genomes from each of the replicate A P10, P15, 
and P20 populations. For each population, we generated ~40,000 ONT reads that mapped 
to the VC-2 reference genome (Table 4.1), with a mean read length of about 4kbp. To 
identify reads containing K3L, we selected all reads that aligned to the repetitive unit 
containing K3L (Figure 4.2) at least once. Variant calling using this ONT read set 
showed that population-level K3LHis47Arg variant frequencies were nearly identical to 
those estimated using prior Illumina MiSeq data (Figure 4.1). Total coverage at the 
K3LHis47Arg variant site was approximately equal in both data sets (Table 4.1). Thus, 
despite an error rate of approximately 8% (Jain et al., 2016), ONT long read sequencing 
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accurately and reliably identified a single nucleotide variant within VACV genomes. 
We next categorized ONT reads containing K3L into single-copy or multicopy 
reads. Reads that unambiguously mapped to the K3L locus a single time were classified 
as single-copy. Since the VC-2 reference sequence itself contains a single K3L gene, if 
more than one distinct portion of a read aligned to the full length of the K3L repetitive 
unit, it was instead classified as multicopy (Figure 4.2). We then further selected reads 
that mapped to unique sequence in the VC-2 reference genome at least 75bp upstream 
and downstream of the repetitive unit, and thus encompass the total number of K3L 
copies from a given viral genome. These methods resulted in a set of reads for replicate A 
populations (ONT-K3L CNV read set) that represents a snapshot of K3L copy number in 
viral genomes at each passage analyzed. 
We utilized the ONT-K3L CNV read set from P10, P15, and P20 to gain a 
detailed understanding of K3L copy number within the different virus populations. The 
majority of reads contain between one and five copies of K3L, and this distribution does 
not change between the P10, P15, and P20 populations (Figure 4.2). These data are 
consistent with our Southern blot analyses (Figure 4.1), and suggest that a dynamic 
recombination process can generate stable copy number increases at the population level. 
Given our average read length of ~4kbp, we may be limited in our discovery of viral 
genomes with greater than 10 K3L copies. Specific long read DNA library preparations 
could allow for increased read length in the future. However, we did identify some reads 
containing high K3L copy number within the ONT-K3L CNV read set, with a maximum 
of 21 K3L gene copies in a single read (Figure 4.2). The largest of these tandem arrays 
correspond to significant increases in genome size, which could incur a fitness cost to 
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maintaining an extremely large genome. However, genomic additions of similar size have 
been shown to have little impact on replication efficiency (Smith and Moss, 1983). Thus, 
while an excess of sequence is tolerated, the bias towards low copy number is consistent 
with an equilibrium between the benefits of extra gene copies and the cost of a large 
genome size. 
 
Concerted evolution of a point mutation within viral genomes 
We next analyzed the ONT-K3L CNV read set for the presence of the K3LHis47Arg 
variant within genomes of varying K3L copy number across P10, P15, and P20 
populations. Our analysis demonstrates that the variant frequency within reads containing 
up to five K3L copies closely resembles the population frequency at each passage (Figure 
4.3). Although the vast majority of reads (~90%) contain between one and five copies of 
K3L, we observed similar distributions of the SNV within reads containing greater than 
five K3L copies (data not shown). Thus, our analysis of the ONT-K3L CNV read set 
suggests that there is no overall bias of the K3LHis47Arg variant towards lower or higher 
copy number genomes. One outlier is within the P10 population, where we observed that 
single-copy reads contained the K3LHis47Arg variant at a greater frequency than the 
population. This suggests that the K3LHis47Arg variant may have arisen in a single-copy 
virus, and then spread across multicopy viruses via recombination. 
To determine exactly how a SNV spreads through tandem gene duplications 
within viral genomes, we identified the precise order of wildtype (WT) and variant alleles 
of K3L in multicopy reads. Utilizing the ONT-K3L CNV read set from P10, P15, and 
P20 populations, we identified the presence or absence of the K3LHis47Arg SNV in each 
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K3L copy of a multicopy read. As expected based on the population-level variant 
frequencies, we observed that most reads contain all WT K3L copies at P10, a split 
between WT and variant K3L arrays at P15, and all variant K3L copies at P20, 
independent of total copy number in the read (Figure 4.3). In all populations, there is a 
bias towards multicopy genomes harboring homogenous K3L arrays, in which genomes 
contain either all WT or all variant copies of K3L, although we also observe some 
multicopy genomes with mixed combinations of K3L alleles (Figure 4.3). If the 
accumulation of the K3LHis47Arg variant were random, one would expect most multicopy 
genomes to contain a mixed set of WT and variant alleles, as there are more possible 
combinations of mixed alleles than homogenous alleles. Instead, we see a striking "all-or-
none" scenario in all populations. Even at P15, when the variant is present at an 
intermediate frequency, multicopy genomes with entirely WT or variant alleles 
predominate. This pattern is reminiscent of concerted evolution, a molecular process 
leading to the homogenization of DNA sequences belonging to a repetitive gene family 
(Dover et al., 1982). Concerted evolution has been observed in many organisms 
(reviewed in Elder and Turner, 1995; Liao, 1999), but has not previously been observed 
in viruses. We suspect that the unique recombination abilities of poxviruses drive rapid 
homogenization of these gene arrays, allowing concerted evolution to proceed. Vaccinia 
virus could thus provide a tractable model in which to test the mechanisms driving this 






Recombination affects concerted evolution to drive adaptive outcomes 
Concerted evolution in these virus populations is likely dependent upon 
recombination dynamics, which can affect adaptive outcomes for the population. The 
rapid homogenization of the K3LHis47Arg variant within gene arrays through 
recombination could occur either between replicating genomes from a single infection 
(intragenomic), or between co-infecting viruses (intergenomic). To test whether the 
pattern of concerted evolution is affected by changes in intergenomic recombination 
rates, we altered the multiplicity of infection (MOI) during passaging. We repeated P10 
to P15 using a 4-log difference in MOI (1.0 - 0.001), to determine whether increasing or 
virtually eliminating the chance of intergenomic recombination would affect the way the 
K3LHis47Arg variant accumulated within the virus population. All populations show similar 
gains in fitness following passaging, independent of MOI (Figure 4.4). This result 
suggests that adaptation to the selective pressure conditions is robust to changes in 
intergenomic recombination rates. Examination of P15 viral genomes from each 
population using ONT sequencing will allow us to test whether accumulation of the 
K3LHis47Arg variant tracks with increases in fitness. These analyses should reveal whether 
concerted evolution is affected by or robust to changes in intergenomic recombination, 
and provide insight into the contribution of intragenomic recombination to the process. 
The rapid homogenization of the K3LHis47Arg variant within gene arrays in 
response to selection in HeLa cells could provide immediate fitness benefits, as well as 
alter future adaptive outcomes. Genetic changes beneficial in one environment can 
positively or negatively affect the way a virus population adapts to different selective 
pressure conditions. For example, we previously observed a collapse of K3L copy 
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number in the P10 population under relaxed selective pressure, and most individual 
clones contained a single allele of K3L, whether WT or K3LHis47Arg (Elde et al., 2012, 
Figure 4.4). These data suggest that low K3L copy number is favored in these conditions, 
and multicopy virus clones are biased against a mixed set of K3L alleles. This implies 
that at P10, concerted evolution may already have played a role in the potential viral 
clones that can emerge from a diverse starting population. To test whether the presence of 
the K3LHis47Arg variant at higher frequencies affects the population dynamics when 
selective pressure is altered, we performed the same experiment with the P15 and P20 
populations. Plaque purification of individual viral clones in a permissive cell line to 
relax selective pressure revealed a similar bias towards single or low-copy K3L genomes 
with a single K3L allele, but an increase in the proportion of clones harboring the 
K3LHis47Arg variant (Figure 4.4). The abundance of K3LHis47Arg clones following plaque 
purification closely matches the population-level K3LHis47Arg variant frequency for each 
passage (Figures 4.1, 4.4). This suggests that under relaxed selection, while low K3L 
copy number is favored, there is no bias towards the WT or variant allele. Thus, the effect 
of concerted evolution is to change the virus population structure, which in turn alters the 
adaptive potential in new environments. 
 
Discussion 
 In this study, we tracked the accumulation dynamics of a point mutation in the 
context of recombination-mediated gene copy number variation during poxvirus 
evolution. Since poxviruses have relatively low point mutation rates, gene amplification 
events are proposed to provide a genetic foothold until further adaptations can occur 
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(Brennan et al., 2014). One such example is a VACV population in which an adaptive 
single nucleotide variant in the K3L gene appeared following K3L CNV (Elde et al., 
2012). We utilized this population (P10) to study the interplay between different types of 
genetic adaptations during additional rounds of selection. Analyses of evolving 
populations using ONT long read sequencing methods revealed new information into 
SNV dynamics in the context of complex genome structures and recombination effects. 
With ONT reads, we were able to precisely determine K3L copy number distribution 
within three viral populations isolated during the course of experimental evolution. 
Interestingly, while additional fitness gains were observed from P10 to P20 (Figure 4.1), 
the distribution of K3L copy number in the viral populations remained relatively constant 
(Figures 4.1, 4.2). In contrast, the K3LHis47Arg variant increased in frequency to near 
fixation by P20, confirmed by near-identical Illumina and ONT-derived variant 
frequency estimates (Figure 4.1). Together, these results suggest that while there may be 
an upper limit to K3L array size that was already established by P10, additional 
adaptations in the form of point mutations can support continued fitness increases in the 
population. 
Our analyses of precise gene copy number and SNV accumulation dynamics were 
only made possible through the use of the Oxford Nanopore system to generate long 
reads capable of spanning complex gene arrays. Other next-generation sequencing 
technologies provide greater depth of coverage, yet despite the increased error rates 
associated with ONT reads, we obtained similar estimates of K3LHis47Arg variant 
frequency in three vaccinia populations using either the Illumina MiSeq or ONT MinION 
platform. These results highlight the utility of ONT sequencing methods for detecting 
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both SNVs and structural variants, which is critical for our analyses of poxvirus 
populations in which recombination as well as point mutations drive rapid adaptation. 
ONT long reads provided a level of detail not possible with short read sequencing 
technologies, and the methods used in this study provide a framework to explore 
mutation and copy number dynamics in other viruses as well. In particular, analyses of 
large DNA virus populations have been limited compared to RNA viruses, in part due to 
differences in genome size. Our work demonstrates the ability of Oxford Nanopore 
sequencing to generate long, high-quality reads with enough yield to investigate DNA 
virus genome evolution in more detail. 
In this study, the accumulation of the K3LHis47Arg variant in a vaccinia virus 
population with stable overall K3L copy number provided a unique data set in which to 
investigate the exact dynamics by which a SNV accumulates in the context of CNV. 
ONT sequencing reads enabled the discovery that selection for the K3LHis47Arg variant is 
independent of gene copy number, since the variant frequency within reads containing 
different K3L copy number closely matches the population-level variant frequency at 
each passage (Figure 4.3). Additionally, our analysis of the pattern of WT and K3LHis47Arg 
variant alleles within multicopy reads revealed a bias towards homogenous K3L arrays, 
consistent with a pattern of concerted evolution (Figure 4.3). At very low (P10) or high 
(P20) variant frequencies, one might expect to observe this “all-or-none” pattern. 
However, even at an intermediate variant frequency in the P15 population, multicopy 
genomes favored either all WT or all K3LHis47Arg copies. Thus, homogenous arrays 
predominate, despite the possibility of recombination between viral genomes, evidenced 
by a variety of allele combinations observed at low abundance in all populations. 
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 Our studies revealed the first instance of concerted evolution in a virus 
population, and we propose VACV as a useful model to delve into the mechanisms 
driving this complex evolutionary process. We demonstrated the utility of the model by 
testing how changes to different experimental parameters, namely intergenomic 
recombination and changes in selective pressure, affect the adaptive outcomes for 
evolving virus populations (Figure 4.4). Altering the rate of intergenomic recombination 
did not affect the ability of virus populations to adapt to the cell line (Figure 4.4), but 
further work is needed to determine whether the K3LHis47Arg variant accumulates as 
fitness increases. Varying the multiplicity of infection while maintaining all other 
variables should allow us to determine whether concerted evolution of the K3LHis47Arg 
variant is dependent on the intergenomic recombination rate. We also showed that 
concerted evolution changes the population structure such that the adaptive potential in 
other environments is affected. Following relaxed selection, we observed that while all 
individual viral clones contained lower K3L copy number, the proportion of clones 
containing the adaptive K3LHis47Arg variant correlated with the starting population 
frequency. Thus, the effect of gene array homogenization is to increase the chance of 
maintaining a variant allele in a different environment. These changes to the population 
structure can impact viral success when entering a new environment, such as during host-
switching events, including zoonoses. 
 In systems ranging from bacteria to mammals, concerted evolution is observed in 
gene families (Liao, 1999), which is not a common feature among viruses. However, 
there are a few examples of gene families in DNA viruses, including poxviruses 
(McLysaght et al., 2003), herpesviruses (Searles et al., 1999), and giant viruses like 
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Mimivirus and Marseillevirus (Colson and Raoult, 2010). Our results demonstrating 
concerted evolution in VACV thus provide a model system to understand how this 
process could affect adaptation in these DNA viruses. This is particularly relevant for 
avipoxviruses, as up to 30% of the genome is composed of gene families (Afonso et al., 
2000). Thus, in addition to understanding variant dynamics during adaptive gene 
amplifications, studies of concerted evolution specific to poxvirus gene families could 
reveal new aspects of poxvirus evolution. Mechanisms elucidated using VACV could 
likely be applied widely, since repetitive sequences evolving in a concerted manner is a 
general phenomenon within diverse systems, and VACV provides a tractable model 
system in which to study the complex mechanisms driving concerted evolution. 
 
Materials and methods 
Cells and viruses 
HeLa and BHK cells were maintained in Dulbecco’s modified Eagle’s medium 
(DMEM; HyClone) supplemented with 10% fetal bovine serum (HyClone), 1% 
penicillin-streptomycin (GE Lifesciences), and 1% stable L-glutamine (GE Lifesciences). 
The P10 strain of vaccinia virus was previously established following 10 serial 
passages of the ΔE3L virus (Beattie et al., 1995) in HeLa cells (replicate C passage 10 in 
Elde et al., 2012). P10 virus was expanded in BHK cells, and titer determined by 48-hour 







Passages were performed as in (Elde et al., 2012), starting with the P10 virus 
population. For each passage, triplicate 150mm dishes were seeded with an aliquot from 
the same stock of HeLa cells (5x106 cells/dish) and infected (MOI = 0.001 – 1.0 as 
indicated) for 48 hours. Cells were then collected, washed, pelleted, and resuspended in 
1mL of media. Virus was released by one freeze/thaw cycle followed by sonication. Viral 
titers were determined between each passage by 48-hour plaque assay in BHK cells 
performed in triplicate. Following passage 20, titers were reassessed simultaneously by 
48-hour plaque assay in BHK cells performed in triplicate. 
 
Deep sequencing of VACV genomes 
Illumina. Total viral genomic DNA was collected as previously described 
(Esposito et al., 1981) from infected BHK cells (MOI = 0.1) 24 hours post-infection. 
Libraries were constructed using the Nextera XT DNA sample prep kit (Illumina, Inc.). 
Barcoded libraries were pooled and sequenced on an Illumina MiSeq instrument at the 
High-Throughput Genomics Core (University of Utah). Reads were mapped to the 
Copenhagen reference strain of vaccinia virus (VC-2; accession M35027.1; modified on 
poxvirus.org) (Goebel et al., 1990) using BWA-MEM (v0.7.10) (Li and Durbin, 2009) in 
default mode. PCR duplicates were removed using samtools (v0.1.18) (Li 2011). Base 
quality score recalibration, indel realignment, and variant calling across all samples was 
performed using Genome Analysis Toolkit (v3.2-2) (DePristo et al., 2011; McKenna et 
al., 2010; Van der Auwera et al., 2013). 
Oxford Nanopore Technologies.  Viral particles were isolated from infected BHK 
		
76	
cells (MOI = 1.0) 24 hours post-infection, and viral cores were purified by 
ultracentrifugation through a 36% sucrose cushion at 18,000 rpm for 80 minutes. Total 
viral genomic DNA was extracted from purified viral cores as above (Esposito et al., 
1981). All sequencing libraries were constructed using an Oxford Nanopore SQK-
NSK007 sample prep kit, and sequenced on a MinION Mk1B device using R9 chemistry 
MinION flow cells (Oxford Nanopore Technologies Ltd.). Sequencing reactions were run 
for 48 hours, and sequenced reads were base-called using the Metrichor cloud-based 
software suite. FASTA and FASTQ sequences were extracted from raw FAST5 files 
using poretools (Loman and Quinlan, 2014). Pooled FASTQ reads for each sample were 
aligned to the VC-2 reference genome as above with BWA-MEM, using the default 
settings provided by the ont2d flag (Li and Durbin, 2009).  
Custom Python scripts (github.com/tomsasani/concerted-evolution-vacv) were 
utilized to calculate both K3L copy number and K3LHis47Arg variant frequency within 
aligned viral reads. Briefly, reads that aligned at least once to the full length of the K3L 
repetitive unit (R.U.) were extracted, and further selected for reads that align at least 75bp 
upstream and downstream of the unit. K3L copy number was calculated within each read 
by summing the total number of alignments to the R.U., including both primary and 
supplementary alignments. Presence of a WT or K3LHis47Arg allele was identified for each 
K3L gene copy within these complete K3L reads, excluding reads that lacked an 
alignment to the reference sequence at the SNV location. All Python code used to 
determine copy number and identify the K3LHis47Arg SNV is available in the above 




Southern blot analysis 
Viral DNA from purified viral cores was digested with EcoRV (New England 
Biolabs), and separated by agarose gel electrophoresis. DNA was transferred to nylon 
membranes (GE Lifesciences) using a vacuum transfer, followed by UV-crosslinking. 
Blots were probed with PCR-amplified K3L using the DIG High-Prime DNA Labeling & 
Detection Starter Kit II (Roche) according to the manufacturer’s protocol. 
 
Plaque purification 
BHK cells were infected for 48 hours with dilutions of replicate A P15 and P20 
viruses, and overlayed with 0.4% agarose. Single plaques were harvested and transferred 
to new BHK dishes, and resulting wells harvested after 48 hours. Virus was released by 
one freeze/thaw cycle followed by sonication. The process was repeated three additional 
times for a total of four plaque purifications. Viral DNA was extracted from 9 single 
clones from each population as above (Esposito et al., 1981), and assessed for K3L CNV 
and the K3LHis47Arg SNV by PCR and Sanger sequencing. 
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Figure 4.1. A single nucleotide variant accumulates concurrently with K3L copy 
number variation. (A) For each passage, HeLa cells were infected (MOI 0.1) for 48 
hours. Titers were measured in BHK cells by plaque assay in triplicate, as mean PFU/mL 
± standard deviation. (B) Variant frequencies were obtained by deep sequencing of viral 
genomic DNA on either the Illumina MiSeq or ONT MinION platform. (C) Digested 
viral DNA was probed with a K3L-specific probe by Southern blot analysis. Size in kbp 































































Figure 4.2. K3LHis47Arg SNV presence within genomes is independent of K3L copy 
number. (A) Representative genome structures of single-copy and multicopy K3L loci 
are shown on top, with the repetitive unit (R.U.) containing K3L and breakpoints 
indicated on each. Representative Illumina MiSeq and ONT MinION reads are shown to 
scale below. ONT reads are classified as single-copy or multicopy depending on how 
they align to the VC-2 reference genome. (B) P10, P15, and P20 viral genomes were 
sequenced using ONT MinION, and single-copy and multicopy reads (ONT-K3L CNV 
read set) were selected and analyzed for the number of K3L copies within each read. The 











































Figure 4.3. Concerted evolution of the K3LHis47Arg SNV within K3L gene arrays. (A) 
The ONT-K3L CNV read sets for P10, P15, and P20 were analyzed for the presence of 
the K3LHis47Arg SNV in each K3L copy. Reads containing 1-5 K3L copies oriented 5’ to 
3’ relative to the VC-2 reference sequence are shown, and the K3LHis47Arg variant 
frequency for each copy is indicated in blue. Total reads for a given copy number are 
indicated to the right of each set of boxes. (B) Stacked bar plots representing the diversity 
of allele combinations within single-copy and multicopy reads were generated from the 
ONT-K3L CNV read sets. The proportion of reads containing homogenous WT, 
homogenous K3LHis47Arg, or any combinations of mixed alleles is shown for reads 



























































































































Figure 4.4. Recombination driving concerted evolution changes adaptive outcomes. 
(A) For each passage, HeLa cells were infected at the indicated MOI for 48 hours. Titers 
were measured in BHK cells by plaque assay in triplicate, as mean PFU/mL ± standard 
deviation. * Titer of P11 (MOI 0.1) was not assessed for technical reasons. (B) Nine viral 
clones from each population were isolated by four rounds of plaque purification in BHK 
cells. K3L copy number and presence of the K3LHis47Arg variant were assessed by PCR 


















































Table 4.1. ONT and Illumina sequencing of replicate A populations. 









Viruses are intertwined with all cellular life in an ever-changing relationship 
between pathogens and their hosts. In the introduction to this dissertation, I described 
some of the myriad ways in which host-pathogen interactions have shaped genome 
evolution. Evolutionary strategies for adaptation exist in various forms, and differ 
between systems. Viruses are no exception, and have adapted to produce an incredibly 
diverse range of reproductive strategies to propagate and evade host defenses. The high 
degree of diversity creates challenges for fighting viral diseases, which pose a constantly 
changing threat to human and animal health. Thus, gaining an understanding of the inner-
workings of different virus types and how they evolve is of critical importance for 
combatting viral infections. Poxviruses represent a virus family with a long history of 
causing severe disease in humans and animals, with the potential for future epidemics. 
Yet surprisingly little is known about how poxviruses evolve. The work in this 
dissertation provides new insights into the mechanisms by which poxviruses adapt, and 
validates experimental evolution studies in vaccinia virus as a means to discover new 
aspects of poxvirus biology. 
 One theme that emerges from this work is the significant role recombination plays 
in promoting poxvirus evolution. Poxviruses represent a tremendously successful virus 
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lineage, yet with a lower point mutation rate compared to RNA viruses (Duffy et al., 
2008; Sanjuán et al., 2010), it was not previously known how these large DNA viruses 
adapt. Our results in Chapter 2 demonstrate a role for recombination-mediated gene 
amplification events in promoting the rapid adaptation of VACV populations in a 
genomic accordion model (Figure 5.1). The striking increase in gene copy number 
illustrates the inherent flexibility of poxvirus genomes, and was discovered by tracking 
evolving virus populations over successive generations. These copy number variation 
events are predicted to be transient, providing a foothold in non-optimal conditions until 
additional adaptive changes can occur and be selected in the population. Consistent with 
this idea, we observed the accumulation of beneficial point mutations following CNV at 
both intragenic (Figure 2.1) and extragenic (Figure 3.1) locations in VACV genomes, and 
a subsequent collapse of variant-containing gene arrays (Figure 2.1). Similar patterns 
have been observed under different selective conditions, in which gene amplifications in 
VACV promoting host switching (Brennan et al., 2014) were followed by the rise of 
adaptive point mutations and a collapse of CNV (Brennan et al., 2015). Together, these 
results provide evidence that structural variants generated by recombination can quickly 
enhance viral fitness allowing and even promoting point mutations. Additionally, the 
identification of adaptive gene amplification events in multiple, independent experiments 
supports recombination-mediated copy number variation as a common mechanism for 
poxvirus evolution. 
 Studies of variant dynamics in poxviruses have been limited, due to large genome 
sizes and the added complexity of recombination effects. Our studies demonstrating 
genetic adaptations in the form of both structural variants and single nucleotide variants 
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uncovers a complex system, and the work in this dissertation reveals new insights into the 
effects of recombination on variant dynamics in poxviruses. In Chapter 3, we found that 
the presence of CNV facilitates the sweep of a point mutation conferring fitness trade-
offs, consistent with structural variation promoting the accumulation of mutations that 
might not otherwise reach fixation. To define the influence of CNV on variant dynamics 
more clearly, we applied new technology with the potential to reveal details of large and 
complex genetic regions. The ability to phase a SNV within a multicopy gene locus 
allowed us to discover patterns consistent with concerted evolution in VACV genomes in 
Chapter 4 (Figure 4.1), which is the first example of this conserved evolutionary process 
in a viral system. It remains to be determined whether gene conversion leading to 
concerted evolution is a common feature of VACV genome evolution, or whether there 
are other adaptive routes for the accumulation of variants in these virus populations. 
Nonetheless, our analyses highlight the utility of long read sequencing to uncover new 
aspects of complex virus population dynamics, with particular application to advance 
evolutionary studies of large DNA viruses. 
 Together, these studies validate VACV as a model system in which to discover 
new elements of poxvirus biology, and to explore complex evolutionary processes with 
broad applications. As with any scientific endeavor, our findings provoke additional 
questions into the complex adaptive mechanisms poxviruses employ, and the VACV 
experimental evolution model can be used in future studies for continued exploration. 
While we observed copy number variation in each of the evolving VACV populations we 
analyzed, there are differences in both the structural variant breakpoints generating 
tandem gene duplications and the suite of potentially beneficial point mutations. This 
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suggests that additional passaging experiments could continue to reveal new adaptive 
strategies. Furthermore, we have only begun to explore potential benefits afforded by the 
point mutations we identified in VACV genomes following selection. Our analyses of 
A24R variants in Chapter 3 suggest complicated mechanisms leading to fitness gains. A 
detailed investigation of viral transcripts could help elucidate the adaptive mechanism, 
and potentially uncover new aspects of transcription control (Appendix B). The other 
high frequency point mutations we identified in the F10L and E9L genes remain to be 
tested for their individual contributions to viral fitness. The E9L gene, encoding the viral 
DNA polymerase, is of particular interest as the vDNAP exhibits recombinase activity 
(Colinas et al., 1990; Hamilton and Evans, 2005), and the same point mutation was 
identified in two independent VACV populations. If the variant affects recombination, 
this could have implications for understanding how the vDNAP mediates recombination 
and any downstream effects on adaptation through gene amplification. There is currently 
no way to alter viral recombination rates without also affecting replication, and thus it is 
difficult to test the effects of recombination on rates of adaptation or genome evolution. 
 The insights we gained through in vitro evolution experiments with VACV 
provide a framework to begin to understand the critical role of recombination during 
poxvirus infection. Our cell culture system allows for rapid evolutionary studies, but it is 
unknown whether recombination and gene amplification play a similar critical role in 
promoting the adaptation of VACV during in vivo infections, which could be performed 
using existing mouse models of infection. Such studies could also have implications 
towards understanding how other, more virulent poxviruses evolve during systemic 
infections. We predict that other poxviruses utilize the same mechanisms of adaptation 
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through recombination, but no studies have yet been performed with other poxviruses. 
Additionally, it remains to be determined whether other large DNA viruses use similar 
recombination-based mechanisms to promote rapid evolution, since virus families such as 
Herpesviridae also possess slower point mutation rates compared to other types of 
viruses (Sanjuán et al., 2010). Giant viruses have the capacity to contain large amounts of 
genetic material, and represent another type of viruses with the potential to utilize gene 
amplification as an adaptive strategy. Thus, our findings highlighting the importance of 
recombination in VACV adaptation beg the question of whether this is a common 
strategy among other virus types. 
 Viruses are ubiquitous, and present a constant yet varied threat to human and 
animal health. An understanding of the adaptive mechanisms driving virus evolution is 
paramount to appropriately respond and defend against viral infections. Collectively, the 
work herein adds significant contributions to virus evolutionary biology by uncovering 
and investigating the role of recombination in promoting the rapid adaptation of 
poxviruses. With respect to ongoing evolutionary host-pathogen conflicts, our results 
contribute to the understanding of different adaptive systems, which we hope will inform 
future investigation of the endless coevolution between viruses and hosts. 
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Figure 5.1. Model of recombination-mediated adaptations in VACV genomes. (A) In 
the genomic accordion model, rapid gene amplification promotes viral fitness and also 
increases the chance of gaining beneficial intragenic point mutations. Under further 
selection, gene arrays can collapse back to single copies containing an advantageous 
point mutation. (B) Copy number variation can also promote the accumulation of 
extragenic point mutations inducing small fitness benefits or even fitness tradeoffs. (C) 
Detailed analyses of multicopy genomes alter the genomic accordion model, and suggest 
that gene amplification and point mutations can occur independently. The point mutation 
is then incorporated into multicopy genomes through recombination, and rapidly 
































RECREATING THE EVOLUTIONARY BIRTH OF 
A VIRAL MIMIC 
 
Introduction 
 Mimicry is a common feature found throughout nature. Visual mimics are 
abundant in ecological settings, such as the classic example of butterflies mimicking 
coloring and patterning between species (Bates, 1862; Müller, 1879; Wallace, 1865). In 
many such ecological cases, there is a predicted fitness advantage to defensive mimicry 
in evading predation (Joron and Mallet, 1998; Malcolm, 1990). These concepts can also 
be applied to host-pathogen interactions, since many pathogens take on features of their 
hosts to evade immune responses. Protein mimics in viruses are particularly prevalent, 
and are often identified by shared homology between viral and host defense genes. Many 
of these protein mimics are thought to arise via horizontal gene transfer (HGT) events 
followed by divergent evolution (Elde and Malik, 2009). The transfer of genetic material 
from the host to a virus is supported by phylogenetic analyses, in which viral genes 
cluster more closely with cellular hosts than with other related viruses (Rappoport and 
Linial, 2012). Viral protein mimics are especially abundant in poxviruses, in which up to 
a quarter of the genome can be composed of acquired host genes (Bugert and Darai, 
2000; Hughes and Friedman, 2005). 
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 Several protein mimics have been identified in poxviruses, which modulate host 
immune responses through retained homology with host factors. These include mimics of 
cytokines, chemokines, immune receptors, complement-regulatory factors, and anti-
apoptosis factors (reviewed in Alcami, 2003; Bugert and Darai, 2000). The collective 
action of poxvirus protein mimics can thus evade, suppress, and prevent host immune 
defenses. One well-studied example of a poxvirus mimic is the vaccinia virus (VACV) 
factor K3L, which is a protein mimic of eukaryotic translation initiation factor 2a 
(eIF2a) (Beattie et al., 1991). Mammalian eIF2a is the substrate of the broadly antiviral 
host defense factor protein kinase R (PKR), which is activated upon infection through the 
detection of foreign nucleic acids (Meurs et al., 1990). Phosphorylation of eIF2a leads to 
a block in translation initiation, and the subsequent loss of protein production inhibits 
viral replication (Safer, 1983). The VACV mimic K3L relieves the translation block 
(Beattie et al., 1991; Carroll et al., 1993) as a competitive inhibitor of PKR, due to 
conserved amino acid and structural identity with eIF2a (Dar and Sicheri, 2002; 
Kawagishi-Kobayashi et al., 1997). VACV encodes a second PKR inhibitor, E3L, which 
prevents PKR activation by binding the activating nucleic acids (Chang et al., 1992; 
Davies et al., 1993). VACV and many other Orthopoxviruses encode both PKR 
inhibitors, which as host range factors likely contribute to a broad host range (Langland 
and Jacobs, 2002). Thus, the key role of K3L during viral infection demonstrates the 
potential fitness advantage afforded by a protein mimic. 
 Protein mimics are abundant in poxviruses, yet there are many questions 
surrounding the origin and evolutionary history of these viral proteins. Homology and 
phylogenetic evidence imply the regular exchange of genetic material from cellular 
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genomes to poxviruses, yet the mechanisms of HGT remain unknown. Interaction with 
the host genome is limited since poxviruses replicate in the cytoplasm of host cells (Moss 
2013), making direct recombination events unlikely. A transposable element was 
discovered within the genome of taterapox (Piskurek and Okada, 2007), suggesting 
retrotransposition as a potential mechanism for HGT, but it remains to be seen whether 
host genes can be similarly inserted into poxvirus genomes through these mechanisms.  
Regardless of the means by which viral genomes acquire a host gene, the selection to 
retain the new genetic material is not well understood. Poxvirus genomes are packed with 
open reading frames, such that random insertion events are expected to be detrimental, or 
neutral at best if the insertion does not disrupt a required gene function. Finally, if a host 
gene is maintained, the process by which a protein mimic evolves to benefit the virus and 
not the host is also unknown. To explore the selection and evolution of a viral mimic, I 
have recreated an ancient HGT event of a host gene into a poxvirus genome. By replacing 
the K3L gene within VACV genomes with eIF2a, I can track adaptive changes within the 
viral-encoded host gene under selection to uncover adaptive processes leading to the 
creation of a mimic. 
 
Results 
Recreating an ancient acquisition event in VACV 
 To reconstruct the acquisition of the mammalian eIF2a gene by a poxvirus, I 
generated a series of recombinant vaccinia virus strains. In these viruses, the K3L open 
reading frame was replaced with different forms of the eIF2a gene (Figure A.1). The 
inserted host sequence is thus under the control of the native vaccinia K3L promoter to 
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ensure transcription from the viral genome. The recombinant viruses were generated 
using a DE3L strain (Beattie et al., 1995), producing DE3LDK3L (DEDK) viruses. 
Knocking out both PKR inhibitors placed strong selective pressure on the recombinant 
viruses to maintain and utilize the host gene. All recombinant viruses contain an EGFP 
marker used for selection, and thus I also introduced EGFP into the DE3L and DEDK 
viruses as controls (Figure A.1). The different eIF2a constructs inserted into the viral 
genome were a full-length gene (DEDK-eIF2a), an eIF2a gene encoding a S51A variant 
(DEDK-S51A), and a C-terminal truncation of the eIF2a S51A gene generating a protein 
of 89 amino acids (DEDK-DC-S51A), similar to the length of K3L (Figure A.1). These 
different constructs represent major differences between K3L and eIF2a, namely lack of 
phosphorylation by PKR and loss of the C-terminus of the protein in K3L. Either of these 
genetic changes could have occurred during or shortly after acquisition by the virus, and 
therefore the different recombinant viruses provide a means of testing whether major 
changes to the host gene affect adaptation within viral genomes. Additionally, this set of 
VACV recombinants simulates a HGT event in which host sequence has been inserted 
into the viral genome, to track whether the virus-encoded host gene is maintained and 
modified under selection. 
 
Immediate viral fitness benefits following insertion of a host gene 
 Following the artificial HGT through the creation of recombinant viruses, I next 
determined whether the insertion of host sequence had immediate effects on viral fitness. 
Since all recombinant virus strains were DEDK, they were generated and maintained in a 
support cell line that stably expresses both E3L and K3L (RK13++) (Rahman et al., 
99	
	
2013). Replication comparisons of the recombinant viruses in RK13++ cells showed that 
there was no significant difference in titer between any of the strains tested (Figure A.1). 
This suggests that insertion of host sequence did not negatively impact general viral 
processes. However, when the viruses were propagated under selective pressure in  
RK13-, HeLa, or BHK cells, all DEDK viruses were significantly impaired compared to 
the DE3L control (Figure A.1). This result corroborates previous findings of the 
requirement for K3L in different cell lines (Langland and Jacobs, 2002) classifying K3L 
as a host range factor. Importantly, under selection, all of the recombinant viruses 
containing eIF2a sequences replicated to equivalent or higher titers than the DEDK virus 
(Figure A.1). These data suggest that VACV can tolerate and, in some instances, benefit 
from the acquisition of host sequence under selective conditions. 
 Interestingly, there were noticeable differences between replication abilities for 
viruses containing different forms of eIF2a. The DEDK-eIF2a and DEDK-S51A viruses 
showed no improvement over DEDK; however, the DEDK-DC-S51A virus displayed an 
increase in titer in all three selective cell lines (Figure A.1). This result suggests that 
while expressing a full-length or C-terminal truncated form of eIF2a from the virus 
genome does not provide any immediate fitness benefit, there is an advantage for viruses 
encoding the S51A variant of eIF2a. The S51A variant is not phosphorylated by PKR, 
yet should still be able to bind the ribosome and participate in translation initiation 
(Hinnebusch, 1994). Thus, by producing excess eIF2a protein which cannot be regulated 
by PKR, the virus likely benefits from the S51A variant relieving the block to translation. 
Conversely, the DEDK-DC-S51A virus does not show similar fitness gains, despite also 
containing the S51A variant (Figure A.1). However, since the C-terminus of eIF2a 
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contains the domain needed for complex formation and interaction with the ribosome 
(Safer, 1983), the DC-S51A form of eIF2a cannot initiate translation. Viral-produced 
eIF2a, even the DC-S51A form, could still act as a competitive inhibitor of PKR, 
allowing endogenous eIF2a to remain active. However, as the DEDK-S51A virus is the 
only strain with detectable fitness gains, this suggests simple overexpression may not be 
enough to affect PKR activity to an appreciable level. Additionally, while the S51A 
variant provides a fitness benefit, the observed increase in titer remains well below DE3L 
levels (Figure A.1). This implies that additional adaptations were required for optimal 
fitness during the creation of K3L. Yet these results suggest that a host gene in its 
original form can be beneficial to a virus immediately following insertion, and that by 
randomly acquiring host sequences, functional genes with fitness benefits may be rapidly 
selected in poxviruses. 
 
Adaptive copy number variation of a host gene within viral genomes 
 With the set of VACV recombinants containing eIF2a genes, I applied an 
experimental evolution approach to follow any fitness and genetic changes that might 
occur over time. One of the advantages to evolutionary studies in a viral system is the 
ability to track genetic changes over many generations, which can reveal mechanisms 
underlying adaptation. To place continued selection on the virus populations to maintain 
and utilize the viral eIF2a gene, I performed serial passages in HeLa cells. All three 
eIF2a-containing recombinant virus populations quickly declined, such that after just two 
passages, there was not enough virus to continue the experiment (Figure A.2). Given the 
extremely impaired ability for these viruses to replicate in HeLa cells compared to other 
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cell lines (Figure A.1), this suggests that the selection pressure may have been too strong 
to allow the viruses to propagate. I next repeated the passaging experiment in RK13- 
cells, in which all of the recombinant viruses showed an intermediate replicative ability 
(Figure A.1). In RK13- cells, the different virus populations maintained a steady or 
slightly increased fitness through four passages, at which point the titer dropped sharply 
(Figure A.2). Thus, while the virus populations were able to persist for longer than in 
HeLa cells, the selection was still too great to permit sustained replication rates. I expect 
similar results in BHK cells, as the initial recombinant viruses reached similar titers in 
RK13- and BHK cells (Figure A.1). In both HeLa and RK13- cells, despite the initial 
fitness benefits observed with the starting DEDK-S51A virus population, there were no 
significant differences between populations over the course of multiple passages. This 
suggests that small initial fitness benefits provided by the S51A variant were not 
sufficient to maintain an advantage under continued selective pressure. 
 Within the RK13- passaged viruses, there were small fitness gains in all three 
populations observed from passages one to four (Figure A.2). To determine whether any 
genetic changes had occurred in the viral eIF2a genes during these early passages, I 
sequenced across the eIF2a locus within viral genomes from passage four (P4) 
populations. This analysis revealed no detectable single nucleotide variants (SNVs) 
within any of the populations. However, I did detect instances in which there were 
multiple copies of eIF2a within individual viral genomes. Copy number variation (CNV) 
has been observed for viral genes in VACV (Brennan et al., 2014; Cone et al., 2017; Elde 
et al., 2012), but this is the first instance of a host gene undergoing copy number 
amplification in a viral genome. Importantly, I detected at least one example of gene 
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amplification in each of the different recombinant virus populations (Figure A.2). This 
suggests that the duplications were independent of gene size, and indeed in some cases, 
other viral genes were also amplified along with eIF2a (Figure A.2). These results are 
consistent with a pattern of random recombination events occasionally creating whole 
gene duplications that are then selected upon. Additional copies of viral eIF2a could 
benefit viral replication through overexpression to overwhelm PKR defenses, although 
this remains to be tested. Another advantage of CNV is the increased chance of gaining 
advantageous point mutations in the expanded gene, which I predict could occur if the 
viruses were able to continue through further passages. Even without knowing the precise 
benefits, the rapid accumulation of viruses with specific amplification of eIF2a suggests 
that recombination-mediated gene amplification following acquisition of a host gene 
represents a mechanism for quickly facilitating adaptation towards the creation of a 
mimic. 
 Selection for increased copy number of eIF2a within viral genomes suggests 
CNV provides fitness benefits, yet these virus populations suddenly declined over further 
passages in RK13- cells (Figure A.2). It is surprising that populations that had increased 
in fitness, even slightly, could so suddenly decrease. To understand how this might occur, 
I tested whether the decline was a direct consequence of selection by host nucleic acid 
sensors. For this experiment, I assessed viral titers from P4 and P5 populations after a 
single 48-hour infection in either RK13- cells or RK13 cells stably expressing E3L 
(RK13+E3L). These data show that expression of E3L in the cell line is sufficient to 
rescue the replication ability of the different viral populations (Figure A.2). Thus, while 
the P4 and P5 populations are severely hindered in RK13- cells compared to the starting 
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populations (Figure A.1), recovery with E3L expression suggests that the replication 
block stems from nucleic acid sensors like PKR. These results also indicate that the extra 
genetic material in P4 viruses containing eIF2a CNV is not causing the replication 
decline, since E3L expression is not expected to affect copy number. Overall, the 
passaging experiments highlight how different cellular environments can differentially 
affect the adaptive ability of a virus population. 
 
Genomic context influences adaptive potential 
 Viral adaptive outcomes following acquisition of a host gene are certainly 
dependent on the environmental selective forces, but other factors may influence 
adaptation as well. My results showing the rescue of poorly replicating passaged 
populations with the expression of E3L (Figure A.2) reveal the importance of the genetic 
context in which a host gene is acquired. By choosing to remove E3L in addition to K3L 
from VACV genomes, I ensured strong selective pressure to maintain the viral copy of 
eIF2a. The passaging experiments showed that this selection is likely too strong to allow 
time for eIF2a adaptations to occur. These results, combined with the fact that E3L and 
K3L act in the same pathway to block PKR signaling, prompts considering whether E3L 
was present when eIF2a was initially introduced into poxviruses. Phylogenetic analyses 
of poxvirus genomes have in fact shown that E3L is likely more ancient than K3L, as 
E3L is shared among a wider range of poxvirus clades (Bratke et al., 2013). Thus, a more 
accurate reconstruction of the eIF2a HGT event should include E3L. 
 In consideration of the genomic context in which eIF2a was likely acquired by 
poxviruses, I created a new series of recombinant poxviruses, this time in the wildtype 
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VACV genome containing E3L. I utilized the same constructs to introduce the three 
different versions of eIF2a as before (Figure A.1), with the only difference being that 
these viruses have a functional copy of E3L (DK-eIF2a, DK-S51A, DK-DC-S51A). 
Replication comparisons of these DK3L recombinant viruses in different cell lines 
showed different outcomes compared to those observed with the DEDK viruses. Titers 
were higher for DK3L viruses in all cell lines tested, due to the expression of E3L 
(Figures A.1, A.3). Consistent with their role as host range factors, E3L was sufficient to 
maintain wildtype levels of fitness in most cell lines, with the exception of BHKs (Figure 
A.3), which require K3L for optimal fitness (Langland and Jacobs, 2002). Under 
selection in BHK cells, the eIF2a-containing viruses displayed slight fitness defects 
compared to the DK3L control, and there was no difference between the three eIF2a 
constructs (Figure A.3). This suggests that the introduction of the host gene was actually 
detrimental under selection. However, as titers were similarly reduced in the RK13++ 
support cell line, yet equivalent to wildtype virus in RK13- and HeLa cells (Figure A.3), 
there may be some other factor affecting viral replication in these recombinant viruses. 
Interestingly, the DK-S51A virus did not show increased replication compared to the 
other eIF2a-containing viruses as was observed in the DEDK background. Any fitness 
benefit afforded by the S51A variant may therefore only be uncovered under stronger 
selection conditions. Together these results suggest that the increased fitness afforded by 







Collectively, these results highlight important insights towards understanding the 
maintenance and evolution of a protein mimic. Based on the data, I propose a new model 
of key adaptive steps in the creation of a viral mimic from an acquired host gene. 
Following HGT of eIF2a into viral genomes, changes to the PKR interface likely 
occurred before loss of the C-terminus of the protein. This hypothesis is supported by the 
finding that the S51A variant was immediately beneficial, while the DC-S51A form of 
eIF2a was not (Figure A.1). While loss of the majority of the original host protein may 
still have been adaptive in the evolutionary history of K3L, my results suggest that 
truncation likely occurred after changes to the PKR binding interface had already 
happened. Mutation of the serine residue in eIF2a may indeed have been a key 
adaptation during the creation of K3L in poxviruses, and I predict changes in PKR 
binding affinity could also result in an improved competitive inhibitor. This type of 
insight is only made possible using evolutionary experiments, and highlights the utility of 
an evolutionary lens to study this type of event. 
Another possible key event in the creation of a mimic is adaptation through 
recombination. Adaptive viral gene copy number amplifications have been previously 
shown to promote the rapid evolution of VACV (Cone et al., 2017; Elde et al., 2012), and 
now I have observed the first instance of CNV of an inserted host gene (Figure A.2). 
Applying selection in different cell lines simulates a host-switching event, in which the 
viral genomic content determines the success of the population. Selection of 
recombination-mediated gene amplification events at the eIF2a locus suggests a benefit 
for viruses containing multiple copies of eIF2a, perhaps through increased protein 
106	
	
expression to inhibit PKR activation in a new host. Further passages are needed to 
explore the continued evolution of the viral-encoded host gene, and while the selective 
conditions I applied in the initial experiments were too strong to allow sustained viral 
populations, the creation of new DK3L recombinant viruses may provide a way forward 
(Figure A.3). While these experiments provide a small window into the early stages of 
mimic evolution, continued observations could allow us to understand how viral protein 
mimics evolve. 
 
Materials and methods 
Cells and viruses 
RK13-, RK13+E3L, and RK13++ cells were a gift from Stefan Rothenburg (UC 
Davis) (Rahman et al., 2013). All RK13-derived cell lines were maintained in minimum 
essential medium, alpha modification (MEM-alpha; HyClone), and HeLa and BHK cells 
were maintained in Dulbecco’s modified Eagle’s medium (DMEM; HyClone), each 
supplemented with 10% fetal bovine serum (HyClone), 1% penicillin-streptomycin (GE 
Lifesciences), and 1% stable L-glutamine (GE Lifesciences). The Copenhagen strain of 
vaccinia virus (VC-2, WT) and the E3L deletion virus (DE3L) (Beattie et al., 1995) were 
a gift from Bertram Jacobs (Arizona State University). 
 
Plasmid constructs 
 We generated a unique multiple cloning site into pBluescriptIIKS (-) (Addgene) 
using primers pB.2_MCS_F (5’-GAGCTCGTTTAAACGCTAGCCATATGGGTACC) 
and pB.2_MCS_R (5’-GGTACC CATATCGCTAGCGTTTAAACGAGCTC). Annealed 
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primers were digested with SacI and KpnI (New England Biolabs) and cloned into 
pBluescriptIIKS (-) cut with the same enzymes to generate pB.2.  Sequences flanking 
K3L from VACV were amplified from VC-2 viral DNA: 680bp of 5’ homologous 
sequence was amplified with the primers K2Lflank_F (5’-CTTCTTATCGATTTTTTAT 
ACCGAACATAAAAATAAGGTTAATTA) and K2Lflank_R (5’-CTTCTTCATATGG 
TGATTGTATTTCCTTGCAATTTAG), and 1024bp of 3’ homologous sequence 
(including the native K3L promoter) was amplified with the primers K4Lflank_F (5’-
CGTCGTGCGGCCGCCTTGTTAACGGGCTCGTAAATT) and K4Lflank_R (5’-CGA 
GCGGAGCTCGTACGATACATAGATATTACAAATATCCTAG). A VACV synthetic 
early/late promoter (SLP) (Chakrabarti et al., 1997) was created by annealing primers 
SLP_F (5’ TCGACAATTGGATCAGCTTTTTTTTTTTTTTTTTTGGCATATAAATA 
AGAAGCTTCCCGGGTCTAGAC) and SLP_R (5’-AGCTCAGATCTGGGCCCTTCG 
AAGAATAAATATACGGTTTTTTTTTTTTTTTTTTCGACTAGGTTAAC). EGFP 
was amplified from pN1-EGFP (Addgene) using primers EGFP_F (5’-
GGAGGACTCGAGATGGTGAGCAAGGGCGA) and EGFP_R (5’-GGAGGTATCGA 
TTTACTTGTACAGCTCGTCCATGC). Each PCR product was digested with restriction 
enzymes (New England Biolabs), gel purified (Zymo Research), and sequentially cloned 
into pB.2 as follows: 5’ flank with ClaI and NdeI, 3’ flank with NotI and SacI, SLP with 
SalI and XhoI, and EGFP with XhoI and ClaI. The resulting plasmid contained EGFP 
following SLP, between the two K3L flanking sequences (pB.2-EGFP).  The K3L open 
reading frame was amplified from VC-2 viral DNA using primers K3L_F (5’-GTTGTAG 
GATCCATGCTTGCATTTTGTTATTCGTTGC) and K3L_R (5’-GTTCTTGTCGACTT 
ATTGATGTCTACACATCCTTTTG). The eIF2a gene was amplified from human 
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cDNA using primers eIF2a_F (5’-GATGTAGGATCCATGCCGGGTCTAAGTTGTAG 
AT) and eIF2a_R (5’-CTACTTGTCGACTTAATCTTCAGCTTTGGCTTCCAT). The 
resulting PCR products were cloned into pB.2-EGFP with BamHI and SalI, placing K3L 
or eIF2a immediately following the native K3L promoter, and upstream of SLP-EGFP to 
create pB.2-K3L and pB.2-eIF2a, respectively. The C-terminal truncation of eIF2a was 
generated by PCR from human cDNA using primers eIF2a_F and eIF2a_DC_R (5’-CCT 
CCTGTCGACTTATCTTCTT TTTGACAAATCAATATATCC). The PCR product was 
cloned into pB.2-EGFP, creating pB.2-eIF2a-DC. Site-directed mutagenesis was 
performed on pB.2-eIF2a or pB.2-eIF2a-DC using primers eIF2a_S51A_F (5’-GATAC 
GCCTTCTGGCTAATTCACTAAGAAGAATCATGCCTTC) and eIF2a_S51A_R (5’-
GAAGGCATGATTCTTCTTAGTGAATTAGCCAGAAGGCGTATC) to generate 
pB.2-eIF2a-S51A and pB.2-eIF2a-DC-S51A, respectively. 
 
Recombinant virus generation 
 Recombinant viruses were constructed by replacing the K3L gene using 
homologous recombination. RK13++ cells were infected with either DE3L or VC-2 (MOI 
= 1.0) and transfected at 1 hour postinfection with pB.2-EGFP, pB.2-K3L, pB.2-eIF2a, 
pB.2-eIF2a-S51A, or pB.2-eIF2a-DC-S51A plasmids by use of FuGENE6 (Promega) 
according to the manufacturer’s protocol. Infected cells were collected at 48 hours 
postinfection, and viruses were released by one freeze-thaw cycle followed by sonication. 
Resulting viruses were plaque purified in RK13++ cells four times, selecting for 
recombinants expressing EGFP. Final virus clones were verified by PCR and sequencing 




 For each passage, 150-mm dishes were seeded with an aliquot from the same 
stock of HeLa or RK13- cells (5 x 106 cells/dish). For P1, dishes were infected with 
DEDK-eIF2a, DEDK-S51A, or DEDK-DC-S51A virus (MOI = 1.0) for 2 hours in a 
minimal volume and then supplemented with medium. After 48 hours, cells were washed, 
pelleted, and resuspended in 1mL of medium. Virus was released by one freeze-thaw 
cycle followed by sonication. 900µl of virus was then used to infect a new dish of cells 
for P2, and the process was repeated for subsequent passages. Viral titers were 
determined using the remaining 100µl of reserved virus stocks from each passage by 48-
hour plaque assay in RK13++ cells. Passages were continued until the virus population 
was below 5 x 104 PFU (MOI < 0.01). 
 
CNV and SNV analysis of viral-encoded eIF2a genes 
 RK13++ cells were infected with P4 DEDK-eIF2a, DEDK-S51A, or DEDK-DC-
S51A viruses (MOI = 0.1) for 24 hours. Virus-infected cells were collected, and total 
viral DNA extracted as previously described (Esposito et al., 1981). The region between 
K2L and K4L containing the different viral-encoded eIF2a genes was amplified by PCR 
with primers K2L_seq_F (5’-GGCATTGGTAAATCCTTGCAGA) and K4L_seq_R (5’-
CACCTTTTAGTAGGACTAGTATCGTACAA). SNV detection was performed by 
sequencing across eIF2a using primers eIF2a_F and eIF2a_R for DEDK-eIF2a and 
DEDK-S51A PCR products, or eIF2a_F and eIF2a_DC_R (5’-CCTCCTGTCGACTTAT 
CTTCTTTTTGACCAATCAATATATCC) for DEDK-DC-S51A PCR products. CNV 
analysis was performed by PCR using primers eIF2a_rep_F (5’-CCTCCTATGGAAGC 
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CAAAGCTGAAGATGAA) and eIF2a_rep_R (5’-CCTCCTATCTACAACTTAGACC 
CGGCAT) for DEDK-eIF2a and DEDK-S51A viral DNA, or eIF2a_DC_rep_F (5’-CCT 
CCTGGATATATTGATTTGTCAAAAAGAAGATAA) and eIF2a_rep_R for DEDK-
DC-S51A viral DNA. Any CNV PCR products formed were sequenced using the same 
primers for breakpoint detection. 
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Figure A.1. Immediate fitness benefits following a simulated HGT event. (A) 
Genome structure of K3L (K3) region in recombinant viruses compared to wildtype 
(WT). (B) Cell lines were infected with the indicated recombinant viruses for 48 hours. 
Viral titers were measured in RK13++ cells by 48-hour plaque assay performed in 




































Figure A.2. Copy number variation of a host gene in viral genomes. (A) DEDK-
eIF2a, DEDK-S51A, or DEDK-DC-S51A viruses were passaged in HeLa or RK13- cells 
until population size was too small to continue passaging. (B) Genomic structures from 
direct sequencing across CNV breakpoints (indicated by arrowheads above each). A 
representative example is shown for each P4 population compared to wildtype. (C) 
RK13- or RK13+E3L cells were infected with P4 or P5 viruses (MOI = 0.1) for 48 hours. 
All viral titers were measured in RK13++ cells by 48-hour plaque assays performed in 
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Figure A.3. HGT genomic context influences adaptive potential. (A) Cell lines were 
infected with the indicated recombinant viruses for 48 hours. Viral titers were measured 
in RK13++ cells by 48-hour plaque assay performed in triplicate as mean PFU/mL ± 
standard deviations. 


























UTILIZING A VIRAL RNA POLYMERASE VARIANT TO 
INVESTIGATE POXVIRUS TRANSCRIPTION 
 
Introduction 
 DNA-dependent RNA polymerases (DdRPs) drive transcription in many 
prokaryotic and eukaryotic organisms, as well as many large DNA viruses. Evolutionary 
analyses have identified universal motifs in the largest polymerase subunit that are found 
in all DdRPs (Sonntag and Darai, 1995). Many viral polymerases share higher 
conservation with eukaryotic rather than prokaryotic DdRPs (Sonntag and Darai, 1995), 
suggesting a deep evolutionary history of similar transcription processes in DNA viruses 
and their hosts. The DdRP in poxviruses, for example, is predicted to have diverged with 
cellular homologues after the split between eukaryotes and prokaryotes (Broyles and 
Moss, 1986), but before the generation of eukaryotic RNA polymerase (RNAP) I, II, and 
III (Sonntag and Darai, 1995). Poxviruses replicate solely in the cytoplasm of host cells 
(Moss, 2013), and thus depend on the viral RNA polymerase (vRNAP) for successful 
transcription and propagation. 
Cytoplasmic replication separates poxviruses from many other large DNA 
viruses, and poxviruses are thus less reliant on host factors for viral mRNA synthesis. 
The vRNAP in poxviruses is composed of nine subunits, and transcribes the set of early, 
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intermediate, and late genes in a temporal manner (reviewed in Broyles, 2003). Gene 
expression control is at the level of transcription initiation, and relies heavily on the 
cascade of viral transcription factors produced throughout the viral lifecycle that 
recognize different viral promoters (Moss, 2013). Early transcripts are produced within 
the viral core immediately following virion fusion, and thus rely solely on viral factors 
packaged in the virion (Broyles, 2003, Moss 2013). Intermediate and late gene 
transcription take place in the cytoplasm post replication, and depend on both viral and 
cellular transcription factors (Broyles, 2003; Oh and Broyles, 2005). It is not well 
understood how transcription factors interact with the vRNAP, or even which host factors 
are required for viral mRNA production. Thus, transcriptional control in poxviruses 
remains an active area of study. 
One key difference between early and intermediate/late genes is the control of 
transcription termination. The vRNAP complex during early transcription includes all 
nine viral-encoded subunits, whereas only eight are found in the post-replicative 
transcription complex (Wright and Coroneos, 1995). The extra subunit is important for 
recognition of a specific termination signal in early genes, leading to homogenous 
transcript lengths (reviewed in Piacente et al., 2008). In contrast, there is no identified 
intermediate/late gene termination signal, although there is evidence to support an active 
termination mechanism (Condit and Niles, 2002). The result is extremely heterogeneous 
3’ ends for intermediate and late transcripts, ranging from 2-5kbp in length (Cooper et al., 
1981; Mahr and Roberts, 1984; Xiang et al., 2000). The mechanisms determining post-
replicative transcription termination thus remain largely unknown. Most of the current 
knowledge surrounding poxvirus transcription stems from studies of the model poxvirus, 
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vaccinia virus (VACV), and I propose to utilize a VACV vRNAP variant that I identified 
in Chapter 3 (Cone et al., 2017) to uncover new aspects of poxvirus transcription control. 
 
Results 
 Poxvirus transcription is mediated by the viral RNA polymerase in complex with 
viral and cellular factors. Transcription control is critical for both the propagation of virus 
particles, and the evasion of host nucleic acid sensors. Double-stranded RNA (dsRNA) is 
produced by many different viruses (Weber et al., 2006), and activates broadly antiviral 
host cytoplasmic dsRNA sensors like protein kinase R (PKR) and oligoadenylate 
synthetase 1 (OAS-1) (reviewed in Sparrer and Gack, 2015; Wu and Chen, 2014). In 
VACV, dsRNA is formed by overlapping, complementary mRNA transcripts (Boone et 
al., 1979; Colby and Duesberg, 1969), and likely exacerbated by the long, heterogeneous 
3’ untranslated regions of intermediate/late transcripts (Cooper et al., 1981; Mahr and 
Roberts, 1984). Thus, alterations to transcription termination control could reduce 
dsRNA production and activation of host sensors. In Chapter 3, I identified a variant in 
the VACV A24R gene, encoding a subunit of the vRNAP, that arose in a DE3L virus 
population under selection to adapt to PKR sensing (Cone et al., 2017). This A24R 
Leu18Phe variant was sufficient for a fitness increase under selective conditions, and also 
reduced total dsRNA production. While there was no resulting effect on OAS-1 activity, 
surprisingly, the A24R variant increased activation of PKR. Thus, while the mechanism 
by which the variant confers an advantage is unclear, these results suggest an interesting 
change to viral RNA production induced by the A24R variant. 
 A reduction in dsRNA with a concurrent increase in PKR activation suggests that 
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there is likely something different about the quality, rather than the amount, of viral 
RNAs being produced in the presence of the A24R Leu18Phe variant. Previously 
identified mutations in A24R have previously been shown to reduce transcript length 
(Condit et al., 1991; Prins et al., 2004), which could affect total dsRNA levels. To 
determine whether the A24R Leu18Phe variant similarly induced changes to transcript 
length, we performed RNA-seq of viral transcripts. The A24R Leu18Phe variant 
provided a small fitness benefit under selection in human fibroblast (HF) cells; however, 
because it arose in a DE3L background, replication was still reduced compared to a 
wildtype virus (Cone et al., 2017). Therefore, to optimize transcript production for 
sequencing, we chose to collect RNA from infected HF cells in which PKR had been 
knocked down (HF-shPKR) (Child et al., 2012). This maintains the HF environment, 
while increasing replication for both the A24RLeu18Phe recombinant virus and the DE3L 
control (Figure B.1). Interestingly, the fitness increase observed with the A24RLeu18Phe 
virus in HF cells is not maintained in HF-shPKR cells (Figure B.1). This suggests that the 
adaptive benefit is dependent on PKR, and supports a complex mechanism of action since 
increased PKR activation in HF cells is not expected to aid replication. However, this 
result supports the need to understand the subtle changes to viral RNA that might 
underlie these phenotypes. 
 To analyze viral transcript length, we sequenced total RNA from DE3L or 
A24RLeu18Phe-infected HF-shPKR cells. Sequencing was performed on the Oxford 
Nanopore Technologies MinION platform, which with long read sequencing capabilities 
has the potential to sequence an entire transcript in a single read. We obtained over 4,000 
viral reads for each sample, with an average read length of about 2kbp. Comparisons of 
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overall transcript length from this analysis showed no significant difference between 
transcripts produced by the DE3L or A24RLeu18Phe virus (Figure B.1). This suggests that 
while the A24RLeu18Phe virus produced less total dsRNA (Cone et al., 2017), it was not a 
result of overall transcript length reduction. However, since it is predicted that 
intermediate/late genes are primarily responsible for dsRNA production (Boone et al., 
1979; Colby and Duesberg, 1969), we also assessed whether different types of transcripts 
showed alterations in transcript length. For this analysis, we selected reads aligning to 
individual viral genes, and again saw no difference between the DE3L or A24RLeu18Phe 
virus transcripts, regardless of whether they were from early, intermediate, or late class 
genes (Figure B.1). While these data suggest that there is no change to overall or 
individual transcript length with the A24R Leu18Phe variant, we propose that additional 
analyses with increased depth of sequencing could reveal differences among a subset of 
viral genes. Additionally, analyses of transcript abundance, which were not feasible with 
our initial low depth of coverage, could provide insight into whether certain transcripts 
are differentially regulated in the presence of the A24R variant. 
 
Conclusions and future directions 
 While preliminary experiments analyzing viral transcripts produced by a vRNAP 
variant did not show differences in transcript length, our combined results suggest that 
the A24R Leu18Phe variant could be used to investigate additional aspects of poxvirus 
transcription. The observed reduction in total dsRNA, increase in PKR activation, but no 
effect on OAS-1 activity with the A24R Leu18Phe variant are consistent with a subtle 
change in viral transcription that effects some, but not all transcripts. Changes to 
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transcript termination are still possible, since our initial RNA-seq analysis did not provide 
complete genome coverage or enough depth to assess transcript abundance. Furthermore, 
the early transcripts we analyzed showed an unexpected amount of variation in length 
(Figure B.1), given the mechanisms regulating early gene transcription termination 
(Piacente et al., 2008). This suggests that at the late time point we analyzed transcripts, 
the reads mapping to early genes may represent read-through of intermediate/late genes 
or aberrant use of early promoter elements by the post-replicative transcription complex. 
Thus, a more in-depth analysis of viral transcripts at different times post-infection is 
needed to assess whether or how the A24R Leu18Phe variant affects viral transcription. 
We expect that such a thorough analysis could reveal subtle changes in the transcriptome 
that may account for the phenotypes observed. 
 Additional sequencing experiments could also reveal new insights into vaccinia 
transcription control. Oxford Nanopore Technologies recently released a direct RNA 
sequencing platform, which could greatly aid in analysis of viral transcripts in their 
original form. Added selection for different subsets of transcripts could provide a more 
targeted analysis of the VACV dsRNAs that activate sensors, such as using a stranded 
RNA preparation to identify overlapping transcripts, or isolating capped mRNAs to 
ensure sequencing of whole transcripts and not fragments. We also expect that pull-down 
experiments with a dsRNA or PKR antibody prior to RNA sequencing could reveal the 
dsRNAs produced during viral infection that bind and activate PKR, which is currently 
unknown. Finally, to stabilize viral transcripts and improve yield for sequencing, we 
could utilize a cell line in which the host 5’-3’ exonuclease, Xrn1, is knocked down. 
However, recent studies showed that along with poxvirus-encoded decapping enzymes, 
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Xrn1 is required to reduce dsRNA levels during infection (Burgess and Mohr, 2015; Liu 
et al., 2015). Thus, while Xrn1 knockdown enhances the antiviral activities of PKR and 
OAS (Burgess and Mohr, 2015), it would be interesting to test whether the A24R 
Leu18Phe variant confers resistance to these conditions. We predict that it would, based 
on the reduction of dsRNA during A24RLeu18Phe virus infection with a tolerance for 
increased PKR activity. However, it may require moving the A24R variant into a 
wildtype background in which E3L is expressed to allow sufficient virus replication. Any 
of these future experiments could elucidate new aspects of poxvirus transcription control, 
and the relationship between viral dsRNA production and activation of host sensors. 
 Another avenue for pursuit using RNA sequencing of viral transcripts is to 
investigate the role for the adenosine deaminases acting on RNA (ADARs), which use 
dsRNA as a substrate. ADARs edit and destabilize dsRNAs through the deamination of 
adenosine to inosine, and can thus affect dsRNAs produced during viral infections 
(reviewed in Samuel, 2011). ADARs generally reduce interferon responses through an 
unknown mechanism (Samuel, 2011), and one isoform of ADAR1 is interferon-induced 
(George et al., 2011; Toth et al., 2006), consistent with a regulatory role for ADARs in 
controlling interferon responses. The role for ADARs during viral infection are complex, 
and in fact can be antiviral or pro-viral depending on the virus and cellular host (Samuel, 
2011). ADARs have been shown to directly edit viral RNAs, but it is unknown whether 
editing occurs on poxvirus RNAs (Samuel, 2011). ADAR1 can suppress the activation of 
PKR during viral infection (Nie et al., 2006; Toth et al., 2009), but interestingly, the 
VACV E3L protein inhibits both PKR (Chang et al., 1992) and ADAR1 (Liu et al., 
2001). E3L and ADAR1 share homology in the Z-DNA binding domain (Patterson and 
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Samuel, 1995), which may contribute to the mechanism of inhibition by E3L. These 
confusing observations demonstrate the need to understand how ADAR activity affects 
poxvirus-produced dsRNAs and viral replication. 
 The abundant dsRNAs produced during poxvirus infections, and the cytoplasmic 
location of transcription coinciding with ADAR1 localization, makes poxvirus transcripts 
a likely target for editing. One method to determine whether ADARs act on poxvirus 
transcripts is to utilize the RNA sequencing analyses we proposed above. Identification 
of A-to-G (or U-to-C) changes in viral sequences would be indicative of ADAR activity 
acting directly on viral transcripts. To understand the role of E3L in moderating ADAR1 
activity, alterations to the Z-DNA binding domain could be tested for effects on ADAR1 
inhibition or direct interaction. The relationship between E3L and ADAR1 also has 
implications for the interpretation of our A24R variant results. The A24R Leu18Phe 
variant arose in a DE3L population, which may have exposed the virus to antagonism by 
PKR as well as ADAR1. Perhaps alterations to dsRNA production by the A24R 
Leu18Phe variant affect ADAR1 activity with the trade-off of increasing PKR activity. 
Thus, we would also like to test whether the A24R Leu18Phe variant provides fitness 
benefits through overcoming ADAR1. Determining whether the A24RLeu18Phe virus is 
affected by ADAR1 knockdown could be very informative in this respect. Clearly there 
are a lot of future directions to pursue in understanding the web of interactions between 
viral dsRNA production, host immune responses, and viral evasion techniques. New 
advents in sequencing technology combined with experimental evolution studies provide 




Materials and methods 
Cells 
 HF-shCtrl and HF-shPKR cells (Child et al., 2012) were a gift from Adam 
Geballe (Fred Hutchinson Cancer Research Center). HF-shCtrl, HF-shPKR, and BHK 
cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM; HyClone) 
supplemented with 10% fetal bovine serum (HyClone), 1% penicillin-streptomycin (GE 
Lifesciences), and 1% stable L-glutamine (GE Lifesciences). 
 
RNA-seq 
 HF-shPKR cells were infected with ΔE3L (Beattie et al., 1995) or A24RLeu18Phe 
virus (Cone et al., 2017) (MOI = 20) for 8 hours. Total polyadenylated RNA was isolated 
as in (Yang et al., 2010), followed by rRNA depletion with the NEBNext® rRNA 
depletion kit (New England Biolabs) and mRNA selection with Dynabeads (Thermo 
Fisher Scientific), each according to the manufacturer’s protocol. The cDNA library was 
prepared using a SQK-NSK007 sample prep kit (Oxford Nanopore Technologies), and 
sequenced on a MinION Mk1B devide using R9 chemistry MinION flow cells (Oxford 
Nanopore Technologies). Sequenced reads were base-called using the Metrichor cloud-
based software suite (Oxford Nanopore Technologies), and FASTA and FASTQ 
sequences were extracted with poretools (Loman and Quinlan, 2014).  Reads were 
aligned to the Copenhagen reference strain of VACV (VC-2; accession M35027.1; 
modified on poxvirus.org) (Goebel et al., 1990) using BWA-MEM in default mode (Li 
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Figure B.1. The A24R Leu18Phe variant does not affect transcript length. (A) HF-
shCtrl or HF-shPKR cells were infected with the DE3L or A24RLeu18Phe virus (MOI = 0.1) 
for 48 hours. Viral titers were measured in BHK cells by 72-hour plaque assay performed 
in triplicate, as mean PFU/mL ± standard deviations. (B) HF-shPKR cells were infected 
with DE3L or A24RLeu18Phe virus (MOI = 20) for 8 hours. Total polyadenylated RNA was 
isolated, and cDNA prepared and sequenced on the MinION platform. Viral reads were 
analyzed for transcript length, and the number of reads is shown in parentheses. (C) Viral 
genes with at least 20 reads spanning the open reading frame and any downstream 
sequences were analyzed for transcript length. Data are shown as box-and-whisker plots, 
and there is no significant difference between any DE3L or A24RLeu18Phe virus transcript 




























































EVOLUTIONARY ANALYSIS OF THE INTRACELLULAR 
DNA SENSOR IFI16 
 
Introduction 
 The interactions between viruses and host innate immune receptors can determine 
the outcome of infection. Host pattern recognition receptors detect conserved pathogen-
associated molecular patterns to initiate signaling pathways in the cell and induce an 
immune response (reviewed in Brubaker et al., 2015). These include receptors that detect 
foreign nucleic acids, which are a common feature of viral infections (Goubau et al., 
2013; Sparrer and Gack, 2015). Viruses have evolved a number of mechanisms to inhibit 
these host nucleic acid sensors (Chan and Gack, 2016), highlighting critical interfaces 
between viruses and cells during the initial stage of infection. Since the outcome of these 
interactions can result in effective immune control or successful infection, there is strong 
selective pressure on both sides to maintain the upper hand. These ongoing conflicts thus 
create an evolutionary arms race between host nucleic acid sensors and viral antagonists. 
Studying these interfaces could elucidate viral immune-evasion strategies and the ways in 
which repeated antagonism has shaped the evolution of host immune responses. 
 Many immune factors are rapidly evolving, likely in response to recurrent 
episodes of selection imposed by pathogens, which act to fix changes that provide a 
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benefit to the host (Daugherty and Malik, 2012). Signatures of rapid evolution have been 
identified in some nucleic acid sensors, including the dsRNA sensors protein kinase R 
(PKR) (Elde et al., 2009; Rothenburg et al., 2009) and oligoadenylate synthetase 1 (OAS-
1) (Hancks et al., 2015), and the cytoplasmic dsDNA sensor cyclic GMP-AMP synthase 
(cGAS) (Hancks et al., 2015). These evolutionary analyses have been used to identify key 
interfaces with viral factors, and the mechanisms by which host sensors have adapted to 
circumvent viral antagonists. This type of analysis could be applied to other host nucleic 




The host protein IFI16 is an intracellular DNA sensor belonging to the pyrin 
domain (PYD)-containing protein superfamily, and interacts with other pro-inflammatory 
factors to induce the production of interferons and interleukin-1β (IL-1β) (Orzalli et al., 
2012; Unterholzner et al., 2010). IFI16 is a broadly antiviral sensor, capable of detecting 
DNA produced during infection with several different viruses, including vaccinia virus 
(VACV) (Unterholzner et al., 2010), herpes simplex virus-1 (HSV-1) (Orzalli et al., 
2012), Kaposi’s sarcoma-associated herpesvirus (KSHV) (Kerur et al., 2011), Epstein-
Barr virus (EBV) (Ansari et al., 2013), and human immunodeficiency virus 1 (HIV-1) 
(Jakobsen et al., 2013). This broad specificity suggests that IFI16 is a critical immune 
defense protein and could be involved in a molecular arms race with viral antagonists. 
I performed an evolutionary analysis to determine whether IFI16 is rapidly 
evolving and potentially engaged in a molecular arms race with viral pathogens. I 
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sequenced the IFI16 gene from a panel of 26 primate cell lines, and using two 
independent maximum-likelihood analyses, found evidence for strong positive selection 
in IFI16 (p < 0.0005). Branch-specific analyses indicated that ancient and recent episodes 
of selection have contributed to the adaptation of IFI16 throughout primate evolution, 
including events leading to the human lineage (Figure C.1). Further analyses of site-
specific positive selection revealed a number of rapidly evolving amino acid positions 
throughout the IFI16 protein (Figure C.1). Patterns of selection dispersed across the 
protein are consistent with a long history of direct interaction with multiple antagonists 
(Daugherty and Malik, 2012). Our results are consistent with ancient and perhaps 
contemporary antagonists driving the rapid evolution of IFI16 in primates. 
 
Discussion and future directions 
 The role for IFI16 during various viral infections and the signatures of positive 
selection I identified suggest that viruses likely possess mechanisms to antagonize IFI16. 
Viral proteins are known to interact with other pyrin domain (PYD)-containing proteins, 
including a poxvirus protein that interacts with the ASC-1 component of the 
inflammasome to inhibit apoptosis and inflammation (Johnston et al., 2005). Interactions 
between pyrin domains suggest that this could be a similar mechanism of action for virus 
proteins to contact IFI16. Indeed, recently, the human cytomegalovirus (HCMV) protein 
pUL83 was shown to interact with the IFI16 pyrin domain, preventing subsequent 
activation of immune signals (Li et al., 2013). Another potential IFI16 inhibitor is the 
HSV-1 protein ICP0, which induces the degradation of IFI16 in certain cell types 
(Cuchet-Lourenco et al., 2013; Orzalli et al., 2012; 2016). Studies to determine whether 
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residues in IFI16 under positive selection affect inhibition by either of these viral 
antagonists could reveal new insights into structural components of IFI16 important for 
such interactions. Changes at these interfaces could elicit fundamental consequences for 
biological function that determine the outcome of infection. Examining these interactions 
could help expose the complex mechanisms driving the evolution of host immune 
responses and viral strategies for immune evasion. 
 
Materials and methods 
Sequence analysis 
 Total RNA was extracted from primate fibroblast cell lines (Coriell), and cDNA 
was synthesized using a Maxima cDNA synthesis kit (Thermo Fisher). IFI16 sequences 
were PCR amplified from cDNA using primers in the 5’ and 3’ UTR of the human 
sequence, and DNA sequences obtained by Sanger sequencing. 
 
Evolutionary analysis 
 DNA sequences were aligned using MUSCLE in default mode, and manually 
trimmed to remove indels. The alignment and a species tree representing currently 
accepted primate phylogeny (Perelman et al., 2011) were used as input files for analysis 
with PAML (Yang, 2007) or HyPhy software on Datamonkey.org (Delport et al., 2010). 
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Figure C.1. Evolutionary analysis of IFI16 in primates. (A) Primate species tree with    
w > 1 values from GA-BRANCH (HyPhy) shown in red, and dN/dS or nonsynonymous:0 
synonymous amino acid substitutions from PAML analysis shown above each branch. 
(B) Schematic of the major domains of IFI16, with positively selected residues from 
PAML analysis (p > 0.95) indicated with open arrowheads above. Amino acid positions 
are shown below. 
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